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ABSTRACT OF THESIS 
INITIAL DEVELOPMENT OF A MULTISTAGE CANCER MODEL BASED ON 
SYRIAN HAMSTER EMBRYO (SHE) CELL TRANSFORMATION STUDIES 
To better incorporate biologic information into quantitative cancer modeling, 
the two-stage MVK (Moolgavkar-Venzon-Knudson) model has been modified 
for use with SHE cell neoplastic progression. Conceptually, five phenotypic 
stages are included in this model: normal cells can either become senescent 
or mutate into immortal cells followed by anchorage-independent growth and 
tumorigenic stages. Cells in each stage have distinct division, death and 
mutation rates, and mutation is assumed to occur during cell division. Model 
development and related experiments were focused on studying the abilities 
of lead, arsenic, c~romium, and a mixture of these three metals to induce 
progression of SHE cells from one phenotype to the next. Cell division and 
death rates were assessed using flow cytometric analysis for inclusion in the 
model. Cell division rates were measured using bromodeoxyuridine (BrdU) 
incorporation with propidium iodide staining, which allows for the calculation 
of potential doubling time, a measure of cell cycle time that takes growth 
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fraction, but not cell loss, into account. Potential doubling times of normal 
SHE cells ranged from 12 to 59 hours, depending on the degree of 
confluence of cell cultures. Cell death was measured by a flow cytometry 
method based on propidium iodide staining specifically related to membrane 
damage. The mean cell death rate is approximately equal to 1 % of the 
average value of division rates. The individual metals and their mixture did 
not induce immortalization or further mutations of SHE cells in our laboratory 
following a 2-day exposure. However, the growth of SHE cells was inhibited 
by 5.4 pM of arsenic, with ce]]s becoming senescent after only 1 6 population 
doublings; whereas, normal cells and cells exposed to lower arsenic 
concentrations lasted for at least 30 population doublings. The model 
developed in our laboratory successfully predicted the growth of normal cells. 
The cell senescence rates under the impact of arsenic exposure were also 
calculated. Mechanisms responsible for induction of cellular senescence in 
SHE cells exposed to arsenic may be involved in the apparent inability of 
arsenic to induce neoplasia in experimental animals. 
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Colorado State University 
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1 . 1 Purpose of the project 
To further incorporate biologic information into quantitative cancer 
modeling, the two-stage MVK model (Moolgavkar-Venzon-Knudson; refer to 
Section 2.2.b; Moolgavkar et a/., 1988; Dewanji et a/., 1989) has been 
modified for use with Syrian hamster embryo (SHE) cell neoplastic 
progression. /n vitro cell culture offers the advantage that cells from 
different stages of the transformation process can be isolated for detailed 
studies. Therefore, it is ideal to measure the parameters needed for 
biologically-based dose-response modeling from in vitro studies. 
Model development and related experiments were focused on studying 
the abilities of lead (Pb2 +), arsenic (As3 +), chromium (Cr3 + + Cr6 +; 1: 1 ratio), 
and a mixture of these three metals to induce progression of SHE cells from 
one phenotype to the next. Laboratory measurements of metal- and metal 
mixture-induced changes in key cell parameters were used to verify the 
development of this modified multi-stage carcinogenesis model. 
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Figure 1. 1 Modified multistage carcinogenesis model for SHE cell 
neoplastic progression 
Five phenotypic stages are included in this model : normal,. senescent, 
immortal, anchorage-independent growth, and tumorigenic. Cells in each 
stage have distinct division, death, and mutation rates, and mutation is 
assumed to occur only during cell division. a j and ~j are the cell division 
and death rates, respectively for cells in stage i. y is the rate of 
senescence of normal cells. Pi is the probability of mutation that a stage i 
cell divides into one stage i cell and one stage j + 1 cell. 
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1 .2 Modified multistage model of SHE cell neoplastic progression 
SHE cells have been used to study neoplastic progression for many 
years, and, as a result, the phenotypic changes exhibited by the cells during 
the carcinogenic process are well defined. Two important advantages of the 
SHE cell system are that the cells exhibit a low frequency of spontaneous 
transformation and that they readily demonstrate neoplastic transformation 
upon treatment with chemical carcinogens (Barrett, 1 993). 
The two-stage clonal growth model that I have chosen to use for the 
cancer modeling purposes in SHE cells incorporates cell division, death, and 
mutation rates into the mechanistic description of malignant transformation 
(Conolly and Kimbell, 1994). Cell division and death determine the 
population growth within each stage. It is further assumed that mutation 
only occurs at cell division. 
The modified multistage carcinogenesis model for SHE cell neoplastic 
progression is shown in Figure 1 .1. Normal cells in culture cease 
proliferation after a limited number of cell divisions, a process called cellular 
senescence. Escaping from senescence to become immortalized is the first 
important step during carcinogenesis in SHE cells and in many other cell 
types. Chemical carcinogens will, at some frequency, induce mutations in 
normal SHE cells that allow them an unlimited life span in culture. As stated 
above, these mutations are assumed to occur only during cell division. 
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I mmortalized cells are easily detected over the background of normal cells by 
continued passage in culture. Over time, normal cells cease proliferating and 
die, while the immortalized clones will gradually take over the culture. 
However, some chemical carcinogens may inhibit the growth of SHE cells 
and shorten their life span instead of inducing immortalization. 
Upon continued treatment with carcinogens, immortalized SHE cells 
will subsequently acquire additional mutations, some of which will confer the 
next important phenotype, that is, anchorage-independent growth. There is 
a strong positive correlation in SHE cells between anchorage-independent 
growth and tumorigenicity (LeBoeuf et al., 1990). Anchorage-independent 
growth can be readily detected by plating the cells in semi-solid media such 
as methylcellulose or soft agar. Colony-forming efficiency under these 
conditions is indicative of a cell's transformed nature. Finally I anchorage-
independent cells may undergo further genetic alterations that confer the 
tumorigenic phenotype, i. e. the ability to grow tumors in immuno-
compromised mice or newborn hamsters. 
In this thesis, I have focused on the first stage (normal cells) and the 
two stages connected to it, immortal and senescent cells. However, it is 
important to note that all the experimental methods developed in our 
laboratory so far can be applied to all of the stages of the carcinogenic 
process in SHE cells. If the model developed through these initial studies 
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appears to be consistent with experimental data for the first two stages, the 
same principles and experimental techniques can be easily applied to the 
subsequent two phenotypic stages. 
Based on the conceptual model presented above, equations can be 
written to describe the time-dependent changes in the populations of normal, 
immortal, and senescent cells. It is assumed that the rate of change in the 
number of normal cells, dN(t)/dt, is proportional to the number of normal cells 
at any time: 
dN(t) 
dt = N(t)· [a1(t)- A(t)]- y(t)· N(t) (1 . 1 ) 
In Equation 1 .1, 0.1 and 131 represent the specific rate of cell division and 
death (units of 1/time) for normal cells; whereas, V is the rate at which 
normal cells convert to senescent cells. 
Similarly, the rate of change in the immortal cells, dl (t)/dt, has the 
same exponential growth property (with 0.2 and 132 being the specific rate of 
cell division and death, respectively), but there is also input of mutated 
normal cells: 
In Equation 1 .2, Jll represents the probability of mutation that a normal cell 
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divides into one normal cell and one immortal cell. Since Jl is a probability 
based on the number of cell divisions, it should be multiplied by division rate, 
Cl, and the number of normal cells. 
The rate of change in senescent cells, dS{t)/dt, is proportional to the 
cell senescence rate, y, and the number of normal cells (Equation 1.3) 
because all senescent cells are converted from normal cells. 
dS(t) 
dt = y(t)·N(t) (1 .3) 
The growth of cells in anchorage independent growth and tumorigenic 
stages will be predicted by the computer simulation method proposed by 
Conolly and Kimbell (refer to Section 2.2.b; Conolly and Kimbell, 1 994). The 
cell growth will be treated stochastically for cells with smaller populations 
and assumed to be deterministic for cells with larger populations. 
As mentioned above, arsenic, lead, chromium, and the mixture of 
these three metals were examined for their effect on the progression of SHE 
cells from one phenotype to the next. Cell division and death rates were 
assessed using flow cytometric analysis for inclusion in the model. Mutation 
rates could be measured by fluctuation analysis. Details of the methods are 




2. 1 Carcinogenesis 
Cancer is a disease caused by uncontrolled cell proliferation. The 
growth of 50 trillion individual cells, which compose the healthy human 
body, are carefully controlled to meet the whole body's needs (Cooper, 
1 992a). Cancer begins when cells become oblivious to the factors that 
control the proliferation of normal cells and continue to proliferate when they 
should not. Cancerous cells are capable of invading nearby tissues from the 
site where they began and become lethal when the tissues and organs 
needed for the survival of the whole body are disrupted (Weinberg, 1 996). 
Two gene classes play major roles in the formation of cancer. They 
regulate the life cycle of the cell through cell growth and division. Proto-
oncogenes motivate cell growth, while tumor suppressor genes inhibit cell 
growth (Weinberg, 1996). Proto-oncogenes can become oncogenes through 
mutation, which results in unending proliferation of cells. Nevertheless, 
tumor suppressor genes are inactivated by mutations that allow cells to 
ignore braking signals and divide excessively (Weinberg, 1 996). It is believed 
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that mutation in at least 6 or more growth-control genes must take place for 
the development of a cancerous tumor (Weinberg, 1996). 
There is strong evidence from human epidemiologic studies and animal 
experiments that the induction of cancer occurs in more than one stage 
(Moolgavkar and Knudson, Jr., 1 981). Based on in vivo experiments, the 
stages of carcinogenesis were historically defined as initiation, promotion, 
and progression (Boyd and Barrett, 1 990). Initiation results from an 
irreversible genetic alteration, while promotion is defined as the clonal 
expansion of initiated cells to a preneoplastic focus or benign tumor. 
Progression is considered as the conversion of a preneoplastic focus or 
benign tumor to a malignant tumor (Boyd and Barrett, 1 990). 
Carcinogens can increase the incidence of cancer in two general ways. 
Initiating agents, or initiators, induce genetic alterations that result in 
uncontrolled cell proliferation (Cooper, 1992b). This group of carcinogens 
includes numerous chemicals and radiation. Other carcinogens, called 
promoting agents or promoters, stimulate cell proliferation instead of 
inducing mutation. Promoters are only effective in inducing tumors when 
initiation stages have been developed (Cooper, 1992b). Examples of 
promoters include hormones and cigarette smoking (Moolgavkar, 1983). 
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2.2. Models for carcinogenesis 
This section begins with the discussion of the development of cancer 
models, followed by a review of the MVK (Moolgavkar-Venzon-Knudson) 
two-stage model which formed the basis of the model developed in this 
thesis. 
2.2.a Development of cancer models 
The multistage theory of cancer-inducing mechanism, which assumes 
a cancer cell is the end-result of a series of discrete mutations, was proposed 
by Nordling (Nordling, 1953). Motivated by the theory, Armitage and Doll 
derived a quantitative multistage model (Armitage-Doll multistage model) I 
which relates the logarithm of incidence rate linearly to the logarithm of age, 
and describes the incidence rate as directly proportional to the dose of an 
applied carcinogen (Armitage and Doll, 1 954). The linearized multistage 
model (Nordling, 1953; Crump, 1996), a generalization of the Armitage-Doll 
multistage model, is the default model for carcinogen risk assessment used 
by Environmental Protection Agency (EPA; Crump, 1996). In the approach 
used by EPA, cancer risks are estimated from a conservative procedure for 
low-dose extrapolation calculated from the data of 2-year animal experiments 
(Portier and Edler, 1990). The linearized multistage model and Armitage-Doll 
multistage model are statistical dose-response models rather than biological 
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models, since actual physiological phenomena, e.g. cell proliferation, are 
ignored in the models. 
To incorporate the kinetics of cell division and death into cancer 
model, Armitage and Doll proposed a two-stage model (Armitage and Doll, 
1 957), the Armitage-Doll two-stage model, which assumes deterministic 
exponential growth for normal and intermediate cells. The stochastic nature 
of the growth of intermediate cells were then introduced to the two-stage 
model by Moolgavkar and colleagues (the MVK model; Moolgavkar, 1979; 
Moolgavkar and Knudson, Jr., 1981; Moolgavkar, Dewanji, and Venzon, 
1988). 
2.2.h The MVK two-stage model for carcinogenesis 
The MVK two-stage model for carcinogenesis (Moolgavkar, 1979; 
Moolgavkar and Knudson, Jr., 1981; Moolgavkar, Dewanji, and Venzon, 
1988) has been recommended as the major model for the risk assessment of 
environmental agents in recent years (Tan, 1991). The advantages of this 
model are that it involves genetic changes and cell proliferation, which are 
believed to be crucial factors in the carcinogenesis process, while remaining 
simple enough to be applicable to human incidence data (Tan, 1991). The 
applications of the MVK two-stage model include the evaluation of risk 
factors of female breast cancer (Moolgavkar et al., 1 980) and the successful 
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fitting of the incidence functions of all human cancers (Moolgavkar and 
Knudson, Jr., 1981). 
The MVK two-stage model incorporates two features: a) transition of 
normal cells to cancer cells via an intermediate stage, as the result of two 
discrete, heritable, and irreversible events, and b) growth and death of 
normal and intermediate cells (Figure 2.1; Moolgavkar and Knudson, Jr., 
1 981 ). The growth of the normal tissue is assumed to be deterministic since 
numerous normal cells are expected to exist at any time. However, the 
growth of intermediate cells is treated stochastically because the transition 
of intermediate cells from normal cells is a rare event. In a small time 
interval, Llt, a normal cell may divide into two daughter normal cells with 
probability atLlt or it may die (or differentiate) with probability PtLlt. It may 
also divide, with a small probability (p,Llt), into one normal cell and one 
intermediate cell which has suffered the first event. During Llt, an 
intermediate cell may in turn divide into two daughter intermediate cells, die 
(or differentiate), or divide into one intermediate and one malignant cell, with 
probabilities of a2Llt, P2Llt, or P2Llt, respectiveJy (Moolgavkar and Knudson, 
Jr., 1981). With the subscripts to distinguish cells in different stages, a, p, 
and P are the birth, death, and transition rates per cell per year. It is 
assumed, in the MVK model, that the number of intermediate cells mutated 
from normal cells by time t is a random variable, which has a Poisson 
1 1 
First Event Second Event 
Figure 2. 1. Two-stage MVK model for carcinogenesis 
N, normal cells; I, intermediate cell; D, dead or differentiated cell; M, 
malignant cells. 011 birth rate (per cell per year) of normal cells; Il, death or 
differentiation rate (per cell per year) of normal cells; J.11 1 rate (per cell per 
year) at which the first event occurs. °21 1l2t and J.12 are defined similarly. 
This figure was adapted from (Moolgavkar and Knudson, Jr"1 1981). 
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distribution with expectation ~,X(s)ds, where Xis) is the number of 
normal cells at time s (Moolgavkar and Knudson, Jr., 1981). 
From the MVK model, the incidence function I(t), which is the rate that 
tumors occur in previously tumor-free tissue, can be computed as 
(2.1 ) 
The details of the mathematical derivation of the MVK model were discussed 
by Moolgavkar and colleagues (Moolgavkar, 1979; Moolgavkar and Knudson, 
Jr., 1 981). The age-specific incidence rate at age t per 100,000 individuals 
in a population is then calculated by /(t) x 105 (Moolgavkar and Knudson, Jr., 
1981 ). 
The MVK two-stage model was incorporated with the phenomena of 
lIinitiation" and IIpromotion" in carcinogenesis and resulted in successful 
predictions. In the framework of the MVK model, the initiator, which acts at 
the level of DNA as mutagens, affects the transition rate of the first event 
(Pt), whereas the promoter, which acts at the cell surface to cause cell 
proliferation, increases the proliferation rate of intermediate cells, i.e. 
increases a2, decreases fJ2' or both (Moolgavkar, 1983). By incorporating 
hormones and cigarette smoke as promoters, the model made a good 
quantitative description of the epidemiology of breast and lung cancers, 
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respectively (Moolgavkar, 1983). 
The analytical solutions of the MVK two-stage model have been 
limited by the number of piecewise-constant intervals, within which the birth 
and death rates are assumed to be constants. The computer simulation of 
the clonal growth cancer model proposed by Conolly and Kimbell (Conolly 
and Kimbell, 1 994) eliminated this constraint. The computational efficiency 
could be highly increased if the growth of intermediate cells are treated as 
stochastically for clones with smaller population and assumed to be 
deterministic for clones with larger population. The improvement on the 
MVK model achieved by computer simulation made this model even more 
applicable to carcinogenesis studies. 
2.3 SHE cell transformation assay 
The Syrian hamster embryo (SHE) cell transformation system was first 
used to examine the carcinogenicity of chemicals by Berwald and Sachs 
(Berwald and Sachs, 1963; Berwald and Sachs, 1965). SHE cells have a 
stable and diploid karyotype. Syrian hamsters contain 44 chromosomes, 
which are similar in morphology and number to human chromosomes 
(Barrett, 1979). SHE cell cultures are prepared from whole embryos and 
contain a mixture of cell types. Some cell types in the mixture have the 
capacity to undergo neoplastic transformation, whereas others have the 
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ability to metabolize chemical carcinogens (Barrett, 1979). In vivo, the liver 
is able to metabolize relatively innocuous precursors to toxic metabolites, a 
process called metabolic activation (Ballantyne et 81., , 995). The ability of 
cells in vitro to metaboHze chemical carcinogens is an important 
consideration when extrapolating carcinogenicity data from an in vitro 
system to humans. 
With the feature of multistep neoplastic progression, the SHE cell 
transformation system has been widely used to study the carcinogenesis 
process, which was believed to include initiation, promotion, and progression 
stages in vivo (Boyd and Barrett, 1 990). This system also provides the 
advantages of a low frequency of spontaneous transformation and readily 
demonstrable neoplastic transformation upon treatment with chemical 
carcinogens (Barrett, 1 993). 
The pathway of SHE cell neoplastic development following carcinogen 
treatment was best described by Barrett (Barrett, 1993) and shown in Figure 
2.2. The earliest phenotypic alteration is morphological transformation, 
characterized by a disorganized and crisscrossed growth pattern in colonies. 
Morphological transformation was not included in the pathway because it is 
not essential for progression to later neoplastic phenotypes, although it is 
associated with an increased probability of the neoplastic progression 
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Figure 2.2. Pathway of Syrian hamster embryo cell neoplastic development 
Normal cells in culture cease proliferation and become senescent after a 
limited number of cell divisions. At least three genetic changes must occur 
before the normal cells become tumorigenic. This figure was adapted from 
(Barrett, 1 993; Preston et al., 1994)). 
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Normal cells in culture cease proliferation after a limited number of 
cell divisions, a process called cellular senescence. Some cells lose 
senescence genes and become immortal, which is a necessary step for 
malignant progression. Cellular senescence is believed to be controlled by 
senescence genes which are activated at the end of the life span of normal 
cells and cause a block to DNA synthesis via down-regulation of cell cycle 
control (Barrett, 1 993). Malfunction of these genes allow cells to escape 
cellular senescence. Senescence genes have been mapped in some 
chromosomal regions, but have not been identified yet (Barrett, 1993). 
At least two additional genetic changes must occur before the 
immortal cell lines become tumorigenic. The changes include (1) loss or 
inactivation of a tumor suppressor gene followed by (2) activation of an 
oncogene (Barrett, 1993; Koi and Barrett, 1986). Cell hybrids between 
carcinogen-induced immortal and tumorigenic cells were formed to determine 
the inactivation of the tumor suppressor gene (Koi and Barrett, 1986). Cells 
retain the ability to suppress tumorigenicity in early passages of immortal cell 
lines (sup +); this ability was reduced or lost in later passages (sup·) (Koi and 
Barrett, 1 986). The phenotype of the sup· cell lines is the ability of cells to 
grow in soft agar in the presence of mitogenic stimuli (Koi et al., 1989; 
Preston et al., 1994). The tumor suppressor genes inactivated in SHE cell 
transformation system remain unidentified; candidates include the putative 
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tumor suppressor genes H19 and TM-1 (Preston, Lang, Maronpot, and 
Barrett, 1994; Hao et al., 1 993; Prasad et al., 1 993). 
The oncogenes activated before cells become tumorigenic in this 
model (Figure 2.2) include the Ha-ras proto-oncogene and non-ras genes 
(Barrett, 1993; Gilmer et al., 1988). The tumorigenicity of cells are 
determined by the ability to form progressively growing tumors in newborn 
hamster or immunocompromised mice. 
Mechanistic studies of genetic and cellular basis of the SHE cell 
transformation system are still in progress. In this particular project, we 
approached this system from a quantitative perspective by incorporating 
cancer modeling with the MVK two-stage model. 
2.4 Metals tested in this project 
Arsenic, chromium, lead, and a mixture of these three metals were 
tested using SHE cell transformation assay. The background of these metals 
are discussed below. 
2.4.a Arsenic 
Arsenic is a ubiquitous constituent in the earth's crust and has been 
used by human since as early as 2000 B.C. It is also a common soil and 
water contaminant that has been found in at least 781 of 1,300 sites on 
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National Priorities List identified by EPA (ATSDR, 1993a). Arsenic can exist 
in three valence states: elemental (zero oxidation state), trivalent (arsenite), 
or pentavalent (arsenate) arsenic (Jolliffe, 1 993). The toxicity of arsenic to 
mammals depends on the valence state, the physical state, and the rates of 
absorption and elimination. Trivalent arsenite is more toxic than pentavalent 
arsenate. The toxicity of inorganic arsenic is usually greater than organic 
arsenic. Arsine gas (AsH3), which is used as a dopant in the production of 
arsenic semiconductors, is the most toxic of all the arsenical compounds 
(Jolliffe, 1 993). 
Arsenical compounds have been used in medicine, electronics, 
agriculture, and wood preservation. For medicinal applications, Fowler's 
solution (1 % potassium arsenite), were used to treat a variety of diseases, 
e.g. psoriasis and syphilis, before 1940. Arsenicals are still used in the 
medicine of sleeping sickness today (Jolliffe, 1993). Because the use of III-V 
semiconductors are increasing, gallium arsenide (GaAs) and indium arsenide 
(lnAs) use in the electronics industry are expected to increase (Yamauchi and 
Fowler, 1994). Therefore, environmental pollution of arsenic by these 
industries is inevitable. Ingesting arsenic-containing water and food is the 
main route of arsenic exposure for general population. Arsenic toxicity 
caused by drinking the well water contaminated by natural sources was 
reported in the United States, Taiwan, Germany, the United Kingdom, Chile, 
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and Argentina (A TSDR, 1990a). 
Arsenite inhibits critical sulfhydryl-containing enzymes and can cause 
overt toxicity results (ATSDR, 1990a). Nevertheless, arsenate can 
competitively substitute for phosphate and causes hydrolysis of high energy 
bonds, as a results, energy needed for cellular metabolism can lose (ATSDR, 
1 990a). Interconversion of trivalent and pentavalent arsenic can be caused 
by oxidation-reduction reactions in vivo. Arsenite can be biomethylated to 
methylarsonic acid and dimethylarsinic acid for renal excretion (Morton and 
Dunnette, 1994). 
Chronic arsenic inhalation is strongly related to lung cancer in human. 
Chronic ingestion of arsenicals is also closely associated with human skin 
cancer and possibly cancers of the liver, kidney, lung, bladder, and colon. 
However, the linkage of cancers to arsenic exposure could not be 
substantiated in experimental animals (ATSDR, 1990a). 
Among other health effects, Blackfoot disease, a peripheral vascular 
disease, was caused by drinking arsenic contaminated well water in Taiwan. 
Raynaud's phenomenon and acrocyanosis were reported in Chile as a result 
of the contamination of the city's drinking water supply (ATSDR, 1990a). 
Hyperpigmentaion, hyperkeratosis, anemia, and leukopenia were also 
reported to be associated with chronic arsenic exposure (ATSDR, 1990a). 
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2.4.b Chromium 
Chromium is commonly used in several industrial processes and has 
been found in at least 115 of 1300 National Priorities List sites that were 
identified by the EPA (ATSDR, 1993b). Chromium has two main forms, 
trivalent (Cr[lll]) and hexavalent (Cr[VI]), that are encountered in biological 
systems (Cohen et al., 1993). Cr(lll) compounds exist naturally in chromite 
ore, whereas Cr(VI) compounds rarely occur naturally and are produced from 
industrial processes, such as chrome plating, leather tanning, pigments, as an 
antirust agent for water-cooled machinery (Costa, 1997). 
Cr(lll) is an important dietary element at very low concentration 
(A TSDR, 1 990b). The trivalent chromium is believed to play an essential role 
in the metabolism of insulin, in the form of "glucose tolerance factor" (GTF) 
which is a complex of Cr(lll), nicotinic acid, and possibly amino acids 
(ATSDR, 1993c). Cr{lll) also plays an important role in the metabolism of fat 
and cholesterol (A TSDR, 1990b). 
Cr(VI) is not needed by human bodies and is extremely toxic. Under 
physiological conditions, Cr(VI) exists as chromate anion (Cr04-
2
), which 
structurally resembles several tetrahedral physiological anions, such as P04-
3 
and S04-2 • As a result, Cr{VI) is readily transported into all cells of the body 
using the general anion transport system (Cohen, Kargacin, Klein, and Costa, 
1993; Costa, 1997). 
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Inhalation, ingestion, and dermal absorption are the routes by which 
chromium enters human body. Cr(VI) is more readily absorbed by body than 
Cr(lll) in all of these three routes because Cr(VI) can penetrates cell 
membranes easily. After entering the body, Cr(lll) tends to bind to plasma 
proteins such as transferrin, an iron-transporting protein (Cohen, Kargacin, 
Klein, and Costa, 1993). In contrast, by using preexisting anion transport 
mechanisms, Cr(VI) crosses cell membranes and is reduced to Cr(lll) inside 
the cell (ATSDR, 1990b; Cohen, Kargacin, Klein, and Costa, 1 993). As a 
result, Cr(lll) accounts for most of the chromium in the body. Bone marrow, 
lungs, lymph nodes, liver, kidney, and spleen have the greatest uptake of 
CrOll) (A TSDR, 1 990b). 
A variety of health effects have been reported for environmental 
exposure to chromium. In Woburn, MA, a fourfold increase in leukemia was 
caused by a high level of Cr(VI) in drinking water consumed by children 
(Costa, 1 997). The level of DNA-protein crosslinks was found to be 
increased in people living in Jersey City, NJ, where chromium-containing slag 
was used as landfill in residential areas (Costa, 1 997). Other effects caused 
by exposing to chromium includes respiratory distress, asthma, skin rashes 
(Costa, 1 997), dermatitis with eczema, liver abnormalities, renal tubular 
necrosis, and, last but not least, lung cancer (ATSDR, 1990b). 
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It has been firmly established in epidemiological studies that an 
increased incidence in respiratory cancers develops following exposure to 
Cr(VI) particles and dusts in industrial processes (Cohen, Kargacin, Klein, and 
Costa, 1 993). Inhaled Cr(VI) has been classified as a human carcinogen by 
EPA and the International Agency for Research on Cancer (ATSDR, 1990b). 
There is not sufficient evidence indicating that Cr(lll) is a human carcinogen. 
In more recently published epidemiological studies, evidence shows 
that soluble Cr(VI) also induces other types of cancers besides respiratory 
cancers, including cancers in kidney, urinary tract, bladder, testes, stomach, 
prostate, and brain (Costa, 1997). Due to the fact that Cr(VI) can be 
absorbed readily by inhalation, ingestion, and skin, these results are expected 
(Costa, 1997). 
Depite the epidemiological evidence indicating that Cr(VI) causes 
human cancers, there is no animal model with natural exposure routes 
(inhalation, ingestion, or dermal absorption) that has shown unequivocally 
positive results for carcinogenicity of Cr(VI) (ATSDR, 1990b). However, 
intratracheal or intrabronchial implantations, intratracheal instillation, and 
subcutaneous implantation of Cr(VI) compounds did induce the formation of 
tumors at the site of application in some studies (Cohen, Kargacin, Klein, and 
Costa, 1993; ATSDR, 1990b). 
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2.4.c Lead 
Since lead has been used from the beginning of civilization, it can be 
found in every part of our environment, including in at least 922 of 1 300 
National Priorities List sites identified by the EPA (ATSDR, 1993d). Most of 
the lead in our environment was from man-made sources such as batteries, 
metal solder and pipes, ammunition, roofing, and x-ray shielding devices. 
Earlier, lead also existed in gasoline, paints, ceramic products, and caulking, 
but the usage was reduced recently due to the health concerns (ATSDR, 
1 993d). Humans could be exposed to lead from drinking water transported 
by lead-soldered plumbing, eating food grown on soil contaminated by lead 
(unleaded gasoline is not required for agricultural vehicles), eating lead-
containing paint chips, and ingesting or breathing contaminated soil, air, or 
water near waste sites (ATSDR, 1993d; ATSDR, 1992). 
Organic lead that is absorbed by the body through inhalation and skin 
contact is metabolized by the liver. Inorganic lead enters the body through 
inhalation and ingestion without undergoing biologic transformation (ATSDR, 
1 992). Smaller particles of the inhaled lead deposited in lower respiratory 
tract are completely absorbed. Ten to 15% of ingested lead, as well as 
larger particles of the inhaled lead which are deposited in upper respiratory 
and moved to gastrointestinal tract by ciliary action and swallowing, are 
absorbed (Putnam, 1986). After being absorbed, lead is distributed to three 
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compartments, blood, soft tissues (kidney, brain, liver, and bone marrow), 
and bones (ATSDR, 1992). Bone contains approximately 95 % of the total 
body burden of lead and serves as an inert pool. Bone lead, which has a 
half-life more than 25 years, can cause elevated blood levels over time, 
especially when the body is under physiologic stress. 
Lead can cause a variety of health effects ranged from relatively mild 
effects to chronic disease and even death. Based on animal studies, the 
Department of Health and Human Services determined lead acetate and lead 
phosphate may reasonably be anticipated as carcinogens (ATSDR, 1993d), 
whereas carcinogenicity of lead in humans is still undetermined due to 
inadequate evidence. Lead also causes central nervous system effects in 
adults, expressed by behavioral changes, impaired concentration, and fatigue 
(ATSDR, 1992). Studies showed that children with high tooth lead levels 
had larger deficits in speech and language processing, psychometric 
intelligence scores, and attention than children with lower tooth lead levels 
(ATSDR, 1 992). For hematological effects, lead inhibits the production of 
hemoglobin by interfering several enzymatic steps in the heme pathway, 
which results in anemia due to the decreased number of red blood cells. For 
reproductive effects, lead causes sterility, increased rate of stillbirths, and 
increased rate of miscarriages (Putnam, 1986). 
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CHAPTER 3 
Materials and Methods 
3.1 Cell culture techniques 
All cell culture techniques and protocols were modified from previous 
studies in our laboratory (Smith, 1997) and those from Dr. LeBoeuf's 
laboratories at The Proctor & Gamble Company (LeBoeuf I Kerckaert, 
Aardema, and Gibson, 1990) for modeling purposes. 
3.1.a Culture medium 
Dulbecco's Modified Eagle's Medium-LeBoeuf's modification (DMEM-L; 
Quality Biological Inc., Gaithersburg, MD) was used throughout the study. 
DMEM-L is a modification of low glucose (1000 mg/L) while DMEM is with 
an equimolar concentration of MgCI2 replacing MgS041 0.75 gIL NaHC031 
and a reduced concentration of phenol red {5 vs. 15 mg/L} (LeBoeuf, 
Kerckaert, Aardema, and Gibson, 1990). Twenty percent of fetal bovine 
serum (FBS; Summit Biotechnology, Ft. Collins, CO) was used in the medium 
for clonal growth and 10% of FBS was used in the medium for serial 
passage of cell lines. L-Glutamine (Life Technologies, Grand Island, NY) was 
26 
added to achieve 4 mM final concentration. Penicillin-Streptomycin (5000 
units/mL penicillin/5000 pg/mL streptomycin; Life Technologies) was used as 
antibiotics and diluted at 1:100 into the solution. The complete medium 
yields a pH of 6.7 while incubated at 37°C with 10% CO2 , 
3.1.b Isolation of primary embryo cells 
Golden Syrian hamsters (Charles Rivers Laboratories, Kingston, NY) at 
gestation day 13 were the sources of the primary embryo cells. The 
methods were previously described by Smith (Smith, 1997) and LeBoeuf et 
al. (LeBoeuf et al., 1989; LeBoeuf and Kerckaert, 1986). Twenty-five to 30 
embryos were obtained from three pregnant animals which were sacrificed 
by CO2 asphyxiation. Embryos were then decapitated, eviscerated, and 
washed in calcium-magnesium-free Hank's Balanced Salt Solution (CMF-
HBSS; Life Technologies) containing Penicillin-Streptomycin (200 units/mL 
penicilJin/200 pg/mL Streptomycin; Life Technologies). To collect cells, the 
embryo tissue pieces were dissociated with CMF-HBSS containing 1 .25 % 
(v/v) trypsin (40X Enzar-T, Intergen Company, Purchase, NY) and 2.5% 
(v/v) pancreatin (4X NFU, Life Technologies). 
Cell viability and density were counted by exclusion of Trypan blue 
stain (0.40/0, Life Technologies) on a Hemacytometer. Twenty million viable 
cells were seeded in each T-150 culture flask (150 cm2 tissue culture flask; 
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Corning). After 24 hours, cells were detached from the flasks using 5 mL of 
Trypsin-EDTA (0.05% Trypsin, 0.53 mM EDTA.4Na; Life Technologies) at 
37°C for five minutes. The cells pooled from flasks were counted and 
diluted to 2 x 106 cells per mL in culture medium with 7.5 % (v/v) dimethyl 
sulfoxide (DMSO; Hybri-Max, Sigma Chemical). One-mL aliquots of this cell 
suspension were frozen in 2-mL cryogenic tubes (Wheaton) at -80°C for 24 
hours and then transferred to liquid nitrogen storage for up to six months. 
3. 1.c Cell preparation for clonal growth 
Syrian hamster embryo (SHE) cells were exposed to chemicals for 48 
hours during the clonal growth period. Two sets of cells were required for 
clonal growth. First, a feeder layer, which was irradiated to cease 
proliferation, was seeded, and then a target layer was plated out above the 
feeder layer and exposed to chemicals. For feeder layer preparation, a vial of 
cryopreserved SHE cell isolate was thawed and seeded in a T -1 50 culture 
flask with 30 mL of culture medium, then incubated at 10% CO2, 37°C, and 
saturated humidity. The cells were re-fed with fresh medium after four hours 
to eliminate the DMSO used in cryopreserving. Three days later, cells were 
trypsinized and gamma irradiated at 5000 rads with a Sherpard & Son Mark 
1, 6000 Curie 137 cesium source. After irradiation, ce)Js were spun down at 
900 x 9 for 10 minutes, resuspended in 10 mL medium, counted, and diluted 
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to 1 0000 cells per mL. This dilution was plated out in 1 OO-mm petri dishes 
(Falcon) at 10 mL per dish as the feeder layer. 
To prepare the target cells, another vial of SHE ceB isolate was thawed 
and seeded in T-25 culture flask with 5 mL of culture medium on the same 
day with feeder layer being plated out. These cells were re-fed with fresh 
culture medium after four hours and grown overnight. The target cells were 
then trypsinized, counted, and diluted to 2000 cells per mL. One hundred 
and two hundred micro liters of this solution, for control and chemical-treated 
groups, respectively I were added to each 100-mm petri dish containing 
feeder layer and 1 0 mL culture medium. These amounts achieved 200 and 
400 target cells per dish for control and chemical-treated groups, 
respectively. After 24 hours, the cells were dosed with the individual test 
metals and the metal mixture in 5 mL of medium and incubated for 48 hours. 
The culture medium containing chemicals was then replaced and the cells 
were allowed to grow for seven days. 
3.1.d Colony isolation and passage 
After seven days of clonal growth, approximately 30 colonies were 
sefected randomly and isolated from control and metals-treated groups, and 
18 colonies from SaP-treated group. To isolate colonies, plastic cloning 
cylinders (Sigma Chemical) were placed on selected colonies and the cells in 
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the cylinders were washed with CMF-HBSS. The cells were then trypsinized 
with drops of Trypsin-EDT A and transferred to separate 60-mm petri dishes 
with 4 mL of culture medium, one colony per dish. It was important at this 
stage to be able to analyze independent colonies, based on the assumption 
that a colony is the expansion of a single parental cell. 
Following the colony isolation, cells needed to be passaged once a 
week. For the control group, each isolate was re-plated at 4 x 104 cells in 4 
mL of culture medium per 60-mm petri dish. For other groups, 1/20 of cells 
were re-plated in each 60-mm petri dish containing 4 mL of culture medium. 
Each isolate was re-plated in parallel in two dishes to prevent the loss of 
isolates due to contamination. Cell lines were determined to be senescent 
when they did not need to be passaged for more than three weeks and 
expressed cytoplasmic spreading. 
3.1.e Growth inhibition study 
During the experiments to induce immortal SHE cell lines in our 
laboratory, arsenic was found to inhibit the growth of SHE cells rather than 
extend the life span. As a result, an experiment was designed to study the 
dose-response growth inhibition caused by arsenic. A vial of cryopreserved 
SHE cells was seeded in T -150 flask and re-fed after 4 hours. Following 
three days of incubation, cells were re-plated in 60-mm petri dishes at 
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4 x 104 cells per dish and incubated for 24 hours. Cells were then exposed 
to arsenic for two days at four concentrations, i.e. LCso of arsenic to SHE 
cells obtained from cytotoxicity studies (Section 3.2) and three 
concentrations below it. The cells were washed and passaged after the 
exposure. The procedures of passaging cells were identical to those 
described in the previous sections. 
3.2 Cytotoxicity study 
To obtain the chemical treatment concentrations for our studies and 
model development, the toxicities of the selected metals {lead, arsenic, 
chromium} and the mixture of these three metals were assessed in SHE cells 
using the MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; 
thiazolyl blue) assay. The chemicals used in this study were lead acetate 
trihydrate, sodium m-arsenite, and the mixture of chromium chloride 
hexahydrate [chromium(lll)] and chromium oxide [chromium(VI)] in a 1: 1 
ratio; all chemicals listed above were purchased from Sigma Chemical 
Company. SHE cells were plated at 96 well tissue culture plates at 6000 
cells per well and incubated for 24 hours. Single metals at graded 
concentrations were added to the medium and cells were treated for 48 
hours. Equi-toxic concentrations were used in the mixture studies followed 
by the single metal studies. 
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After treatment, the cells in each well were incubated with 50 pg of 
MTT (Sigma Chemical) for four hours. MTT yields a ye1Jowish solution when 
dissolved in culture medium. Dehydrogenase enzymes in live cells could 
cleave the tetrazolium ring of MTT and convert it to insoluble purple MTT 
formazan (1-[ 4,5-Dimethylthiazol-2-yl]-3,5-diphenylformazan). Absorbance 
was read on a microplate reader at 550 nm after the MTT formazan crystals 
were dissolved by 100 pL of DMSO. LCso is defined by the concentration at 
which the chemical results in 50% inhibition of absorbance at 550 nm and 
was determined by log plots of percentage of control absorbance versus 
metal concentration. 
3.3 Cell division rate measurement 
Cell division rates were measured using bromodeoxyuridine (BrdU) 
incorporation with propidium iodide staining, which allows for the calculation 
of potential doubling time (Tpot )' Tpot is a measure of cell cycle time that 
takes cell growth fraction, but not cell (oss, into account (Steel, 1977; 
Wilson, 1994). After obtaining Tpotl the cell division rate, a, was calculated 






3.3.a Potential doubling time method 
The division rate was estimated from the potential doubling time that 
could be calculated by Equation 3.2, 
(3.2) 
where Ts is the period of DNA synthesis, LI (labeling index) is the fraction of 
cells synthesizing DNA, and A is a correction factor for the nonlinear 
distribution of cells through the cell cycle (Steel, 1977; Wilson, 1994). 
Potential doubling times were measured in flow cytometry by pulse-
labeling cells with bromodeoxyuridine (BrdU) and detected its incorporation 
into DNA by the use of fluorescent antibodies. The cells were then 
counterstained by propidium iodide to measure the DNA content. Estimation 
of Tpot values relied upon distinction of cells in different stages of the cell 
cycle. The cell cycle contains four stages (Figure 3.1). The cell increases in 
size and prepares for DNA replication in the G1 (gap one) phase. In the S 
(synthesis) phase, the cell replicates its nuclear DNA. In the next gap period 
(G 2 phase), the cell confirms that DNA replication is complete before it 
proceeds through mitosis (M), in which the cell finally divides into two 
daughter cells. 
The results from a representative flow-cytometry study are shown in 
Figure 3.2 and discussed here to illustrate the method. Each window in 
33 
Figure 3. 1. The four stages of a cell cycle 
The cell cycle proceeds clockwise through four successive stages (G 1: gap 1 
; S: synthesis; G2 : gap 2; M: mitosis) 
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R.ed fluorescence (DNA content) 
Figure 3.2. Bivariate histograms of BrdU Fncorporation versus DNA content 
Panels present bivariate histogra,ms obtained from cells stained at 0, 2, 4, 
and 6, hours after BrdU pulls,e-labelin'g. X-ax.is is intensity of red 
fluorescence (DNA content), y-axis is intensity of green f luorescence (SrdU 
incorporated). All cells were stained by propidium iodide with intensities 
proportional to DNA content, while cells in S phase during SrdU pulse~ 
:Iabeling were, labe'lled by BrdU (green contours). 
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Figure 3.2 is a bivariate histogram containing the green fluorescence (BrdU 
incorporated) on y-axis and red fluorescence (DNA content) on x-axjs. The 
left-top window presents the histogram immediately after BrdU pulse-labeling 
(0 hour). The cells labeled with BrdU (S phase) lay between two groups 
without green fluorescence, G1 on the left and G2/M on the right. 
After two hours, the green population (S phase cells) moved to the 
right while a small population appeared as G1 phase cells. That is because 
most of the BrdU-labeled cells moved through S phase to G2/M and a small 
population were in or had completed mitosis and divided into daughter cells 
(i. e. G 1 cells) . At later time points (i. e. four and six hours), there was an 
increasing number of cells that had divided and now appeared on the left side 
as G1 phase cells. 
Ts can be measured by the relative movement of the BrdU labeled cells 
through a certain region (Begg et a/., 1985). The relative movement (RM) is 
calculated as 
(3.3) 
where FL represents the mean red fluorescence intensity of the BrdU labeled 
cells (Figure 3.3). FG1 and FG2/M are the mean red fluorescence intensity of G1 
and G2/M cells, respectively. FL is approximately in the middle of FG1 and 
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Figure 3.3. The schematic plot for the calculation of relative movement 
Elements contained in Equation 3 .3, used to calculated the relative 
movement, are indicated schematically. FL represents the mean red 
fluorescence of the BrdU labeled cells. F G, and F G2/M are mean red 
fluorescence of G, and G2 /M cells, respectively . 
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FG2/M at time zero, i.e. RM is approximately equal to 0.5. FL will approach 
FG2/M as time passes and RM will be equal to one at Ts. 
By setting RM equal to 0.5 at time zero (Begg, McNally, Shrieve, and 
Karcher, 1 985), the DNA synthesis time can be calculated as 
0.5 
1; = RM _ 0.5 x t (3.4) 
where t is the sampling time. Labeling index is calculated as the proportion 
of cells labeled by BrdU. By assuming "A equal to one, Tpot can be obtained 
from Equation 3.2. 
3.3.b Bromodeoxyuridine/propidium iodide staining protocol 
SHE cells were plated in parallel on 60-mm petri dishes at 4 x 104 cells 
per dish. After 72 and 120 hours, 10 pM of BrdU (Sigma Chemicals Co.) 
was used to pulse-Jabel the cells for 20 minutes. Fresh medium was added 
to the cells after BrdU was removed, and the cells were grown for another 3 
hours. BrdU-labeled cells were then trypsinized and fixed in 70% ethanol, 
which helped propidium iodide to penetrate the plasma membrane. Fixed 
cells could be stored in 70% ethanol at 4°C for months before staining. 
The staining protocol was modified from Larsen (Larsen, 1994). The 
first step of staining was to partially denature DNA to allow access of the 
monoclonal antibody to its epitope on the incorporated BrdU. To achieve the 
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denaturation, 0.2 mg pepsin (Sigma Chemical Co.) was dissolved in each mL 
of 2N HCI and incubated with cells at 37°C for 15 minutes. To terminate 
the denaturation, 1 M Tris (Trizma base, Sigma Chemical Co.) was added to 
the cells which were then washed with PBS. Monoclonal mouse anti-BrdU 
antibody (Dako) was added and incubated with cells for 30 minutes at room 
temperature. After the anti-BrdU antibody was washed out, fluorescein 
isothiocyanate (FITC)-conjugated rabbit anti-mouse antibody (Dako) was used 
to bind to anti-BrdU for 15 minutes at room temperature. For the last step of 
staining, 10 pg/mL of propidium iodide combined with 1 mg/mL of RNase 
were added to create specific DNA binding. Cells were filtered through 53-
pm nylon mesh (Small Parts Inc., Miami Lakes, FL) before flow cytometric 
~nalysis. 
3.4 Cell death rate measurement 
The cell death rates were measured by staining cells with propidium 
iodide. This dye is only taken up by dead cells through the damaged 
membrane and is excluded by live cells (Ormerod, 1 994). Propidium iodide 
binds to nucleic acids and fluoresces red after entering dead cells. By setting 
a gate in the forward angle light scatter (FALS), which is an indicator of cell 
size, debris and clumps could be excluded from flow cytometric 
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Figure 3.4. Histograms for death rate measurement 
A: Cells screened by forward angle light scatter: cells in delineated area 
were analyzed for propidium iodide uptake (8). B: Dead cells, which take 
up propidium iodide, show bright red fluorescence (delineated area). 
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basis of their uptake of propidium iodide (Figure 3 .4B), and the fraction of 
death cells in sample was obtained from these measurements. 
SHE cells were plated in parallel at 40000 cells per dish. Samples 
were harvested at 72, 96, and 120 hours after plating. Two mL of Trypsin-
EDTA was used to detach the cells at 37°C for five minutes. In addition, 
medium from the culture and 3 mL of CMF-HBSS used to wash cells were 
collected since dead cells did not attach. After all cells were collected, they 
were shipped to the flow cytometry lab and centrifuged. The pellets were 
resuspended in 1 mL of 50 ,ug/mL propidium iodide and incubated at room 
temperature for five minutes. The stained cells were filtered through a 53-
,um nylon mesh before flow cytometric analysis. 
Since the flow cytometric measurement only provides the percentage 
of dead cells, the total number of cells were counted to allow calculation of 
the number of dead cells. A dish of cells was harvested at the same time 
and by same procedure as were the cells measured in flow cytometry. These 
cells were centrifuged, resuspended in 1 mL of culture medium, and counted 
in hemocytometer under the microscope. 
3.5 Flow cytometric analysis 
Samples were analyzed with an EPICS V cell sorter (Coulter, Miami, 
FL) interfaced to a Cicero data acquisition and display system (Cytomation, 
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Inc., Ft. Collins, CO). Cells were illuminated by an argon ion laser at 488 nm 
(500 mW). FITC fluoresces at wavelengths between 515 to 530 nm and 
propidium iodide fluoresces at wavelengths longer than 61 0 nm. 
For division rate measurement, a gating on peak vs. integral 
fluorescence of the propidium iodide signal was set to eliminate clumped 
cells. Thirty thousand counts of nuclei were triggered by the signal of 
propidium iodide fluorescence. 
For death rate measurement, the gating was set on forward-angle light 
scatter to eliminate debris and clumped cells. Twenty thousand cells were 
counted for each sample. 
3.6 Computer and software packages 
The simulation programs were written in MATLAB® (The MathWorks 
Inc., Natick, MA) and ACSL Tox (ACSL = Advanced Continuous Simulation 
Language; Pharsight Co., Mountain View, CAl software packages. The 
programs were executed using a Gateway P5-200 personal computer 
(Gateway, Inc., San Diego, CAl. 
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CHAPTER 4 
Results and Discussion 
4.1 Toxicities of metals to SHE cells 
The results of cytotoxicity studies of chromium, arsenic, and lead to 
Syrian hamster embryo (SHE) cells are shown in Figure 4.1 and 4.2. The 
calculated LC50 of chromium was 3.6 pM (Figure 4.1 A) and that of arsenic 
was 5.4 pM (Figure 4.18). Lead was not very toxic to SHE cells and killed 
fewer than 50% of the cells, even at the relatively high concentration of 1 
mM (Figure 4.2A). As a result, 100 pM of lead was assumed to have equi-
toxicity to the LC50s of the other two chemicals, and this level was used in 
the metal mixture toxicity study. I.e., multiple dilutions were made from the 
mixture of the LC50s of chromium and arsenic, as well as 100 pM of lead 
(Figure 4.28). The LC50 estimated for the mixture was at the individual 
concentrations of 2.2 pM of chromium, 3.2 pM of arsenic, and 60 pM of 
lead. These results show that a mixture of the three metals exhibited less-
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Figure 4. 1. Cytotoxicity studies of chromium and arsenic to SHE cells 
Cytotoxicity of chromium (A) and arsenic (8) to SHE cells were analyzed by 
MTT assay. The estimated LCsos were 3.6 pM for chromium (A) and 5.4 pM 
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Figure 4.2. Cytotoxicity studies of lead and metal mixtures to SHE cells 
Cytotoxicity of lead (A) and metal mixtures (8) to SHE cells were analyzed 
by MTT assay. For the metal mixture study, multiple dilutions were made 
from the mixture of the LCsos of Cr and As, as well as 100 pM of Pb. The 
estimated Leso for the mixture was at the individual concentrations of 3.2 
pM of As, 2.2 pM of Cr, and 60 pM of Pb. 
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4.2 Attempted induction of immortal cell lines 
Separate cultures of SHE cells were treated by the LC50s of chromium, 
arsenic, and the metal mixture, and by 100 pM of lead for two days. 
Approximately 30 colonies from each chemical treatment were isolated and 
attempted for their ability to become immortal cells following serial passages. 
All cell isolates became senescent before the completion of 21 passages, 
which was calculated to be the equivalent of 112 population doublings. 
Senescent cells were observed to be morphologically distinguishable from 
normal cells (Figure 4.3). Senescent cells were much larger than normal cens 
and were characterized by cytoplasmic spreading, while normal cells grew in 
a flowing manner. The life spans of cell isolates, which were defined as the 
population doublings cells have grown until senescence, were shown in Table 
4. 1. All of the As-treated cell isolates became senescent at the second 
passage, and none of them proliferated for more than 22 population 
doublings, while at least one cell isolate from each of the other three 
treatment groups grew for more than 58 population doublings. These results 
showed that As at 5.4 pM inhibited the growth of SHE cells. The cell isolate 
with longest life span in this experiment lasted for 112 population doublings. 
It was treated with benzo[a]pyrene (BaP), our positive control agent for 
immortalizing SHE cells (LeBoeuf, Kerckaert, Aardema, and Gibson, 1990). 
The cell isolates that lasted longest for Cr and Pb grew for 69 and 101 
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Normal Cells 
CtrU Sp3 1121/99 
Senescent Cells 
Ctrl29p3 1121/99 
Figure 4.3. Examples of normal and senescent SHE cells 
Normal cells have fibroblast characteristics when confluency was reached . 
Senescent cells were much larger than normal cells and expressed 
cytoplasmic spreading. 
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population doublings, respectively. No additive effect was observed in the 
mixture-treated cells, which included one isolate with 58 population 
doublings. 
Thus, none of the treatments induced immortal cells. The reason that 
immortal cell lines were not induced from the positive control group could be 
the exposure period. The experimental protocol was adapted from LeBoeuf 
et al. (LeBoeuf, Kerckaert, Aardema, and Gibson, 1990), in which BaP 
successfully induced immortal SHE cell lines, except that a 2-day exposure 
was used in our laboratory instead of the 7 -day exposure used by LeBoeuf et 
al. Using the 2-day exposure was based on the consideration of applying the 
model to volatile organic chemicals later. Two volatile chemicals, 
trichloroethylene and 1 ,2-dichloroethane, dissolved the plastic dishes in 
previous 7-day exposure studies from our laboratory (Smith, 1997). The 
shorter exposure might not have been sufficient for BaP to induce mutation 
under the culture conditions we selected. 
Arsenic was found to inhibit the growth of SHE cells. Cells exposed 
to chromium, the metals mixture, and BaP showed smaller degrees of growth 
inhibition compared to cells exposed to arsenic. Lead did not inhibit the 
growth of SHE cells. Since arsenic exhibited the greatest impact on the 
growth of SHE cells, the following model development focused on the effect 
on cell growth induced by arsenic. The cell division and death rates 
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Table 4.1: Life Spans of Cell Isolates 
Population Number of cell isolates from each chemical treatment 
Doublings As Cr Pb Mixture Control SaP 
15-20 25 21 6 21 7 15 
20-25 5 6 17 7 10 1 
25-30 1 2 7 
30-40 2 1 1 
40-50 1 2 
50-60 1 1 2 
60-70 2 2 
80-90 1 
>100 1 1 1 
Total 30 30 30 30 32 18 
measured from control cells, while obtained from the experiments described 
above, were also used in the model development. 
4.3 Growth inhibition study by arsenic 
Arsenic was observed to inhibit the growth of SHE cells from the 
results described in Section 4.2. A dose-response study was designed to 
further study the growth inhibition effect caused by arsenic. Four graded 
concentrations of arsenic, 0.5, 1.0, 2.0, 5.4 pM, were used in this study, 
where the highest concentration was the LCso of arsenic to SHE cells. SHE 
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cells were exposed to arsenic for 2 days and their life spans were determined 
following serial passages. Since there was no significant difference observed 
between the growth of cell isolates in the previous experiment (Section 4.2), 
cells were exposed to arsenic at the density of 4 x 104 cells per dish instead 
of 400 cells per dish which was used in clonal growth. Arsenic at 5.4 pM 
shortened the life span of SHE cells, and the cells only grew for 1 6 
population doublings before becoming senescent (Figure 4.4). SHE cells 
exposed to lower concentrations, 0.5, 1.0, 2.0 pM, grew for more than 30 
population doublings and did not show significant difference in growth from 
control cells. 
Cellular senescence induced by arsenic has not been previously 
reported. However, arsenic was found to induce mitotic inhibition in Chinese 
hamster ovary cells (Lee et al., 1986). Furthermore, in vivo, arsenic was 
observed to cause inhibition of the promotion of preneoplastic lesions in rats 
(Pott et al., 1 998) and to decrease tumor incidence in mice (Kanisawa and 
Schroeder, 1967), although the processes underlying these effects remain 
unknown. Mechanisms involved in the induction of cellular senescence by 
arsenic in vitro may also be responsible for the effects observed in vivo. 
Induction of cellular senescence has also been reported with exposure to 
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Figure 4.4. Effect of arsenic on the growth of SHE cells 
Cells exposure to 5.4 pM of only grew for 16 population doublings before 
becoming senescent. All cells exposed to lower concentrations, 0.5, 1 .0, 
2.0 pM, grew for more than 30 population doublings and continued to grow 
beyond the numbers of population doublings shown above. 
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4.4 Cell division rates 






where Tpot is the potential doubling time (Section 3.3). The calculations for 
Tpot values are shown in Appendix A. It was observed in normal cells that 
Tpot was a function of time after each passaging of the cells (Figure 4.5); this 
effect is presumed to be a result of IIcrowding". This result can be explained 
by the phenomenon of IIdensity-dependent inhibition of cell division" I which 
assumes that norma1 cells in culture stop dividing when a confluent 
monolayer is formed (Alberts et al" 1994). Furthermore, a reduction of cell 
growth rates was detected when membrane contact occurred in a study 
conducted by video time-lapse microscopy in newborn rat dorsal root 
ganglion cells (Bandtfow et al., 1 990). 
Short Tpot (high cell division rate) was observed while the cell density 
was low.. As the cell numbers increased, longer Tpot (low cell division rate) 
was measured due to decreased space for cens to grow. Examples of the 
impact of cell density on Tpot are shown in Figure 4.6, where the measured 











40 60 80 100 120 140 160 
Time after cell passage (h) 
Figure 4.5. The change of potential doubling time (Tpot) as a function of 
time after cell passage in SHE cell culture system. 
Tpot was observed to be a function of time after each passaging of the cells. 
The dots represent measured values with error bars representing ± one 
standard deviation. The line represents the result of nonlinear regression 
from the exponential equation Tpot= 12.4+0.0913*exp(O.0432*time). This 
regression had a standard error of the estimate equal to 1.75 h. 
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Cul 40 pS 1128/99 
Ctrl 36 pS 1/29/99 
Figure 4.6. Examples of the impacts of cell densities on Tpot measured 
The first picture (A) was taken on 3 rd day after cells were passaged, when 
the cell density was low and Tpot measured was 13 hours. The other 
picture (8) was taken on the fifth day and there was less space for cells to 
grow. As a result, the measured Tpot was 23 hours. 
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4.6A), and 23 hours on the fifth day (Figure 4.68). Tpot values measured 
from different normal cell isolates showed very consistent results (Appendix 
A). The dots and error bars in Figure 4.5 represent the means and standard 
deviations of Tpot values from different normal cell isolates. To incorporate 
the Tpot values measured into the model as the cell division rate, a nonlinear 
regression calculated by SigmaPlot@ was used to predict the relation between 
Tpot (h) and time after cells were passaged (h), 
Tpot = 12.4 + 0.0913. eO.0432.,ime (4.1 ) 
This regression had a standard error of the estimate equal to 1.75 h. The 
standard error of the estimate (Sy.x) is defined as, 
1 ~ A 2 
SYIX = ---=-3 i..J (1'; - 1';) 
n ;=1 
(4.2) 
where ~ and Y; are the observed and predicted values, respectively, and n is 
the sample size (Kleinbaum et al., 1 998). The range of values representing 
the underlying population generally falls within two standard errors of the 
observed sample mean {SPSS Inc., 1997}. 
4.5 Cell death rates 
Time course studies were used to determine cell death rates. To 
obtain the numbers of dead (0) cells, the total number of cells, which was 
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counted on a hemocytometer, were multiplied by the fraction of dead cells, 
which was obtained from propidium iodide staining and flow cytometric 
analysis (Section 3.4). The cell death rate (~) was assumed to be constant 
within each passage and was defined as the value that made the following 
two equations having the best fit to the experimental data of normal (N) and 
dead (D) cells. 
dN(t) 






where a is the cell division rate. a is a variable and was obtained from 
Equations 3. 1 and 4. 1 (Section 4.4). 
A computer program was written in MATLAB® (Appendix B) to 
optimize the death rate,~. The optimization was achieved by minimization 
of the objective function, 
b
. . F . '"' [(predicted - obSerVed)2] o yectlve unctIon = L..J b d)W (4.5) 
(0 serve 
where w is the heteroscedasticity parameter. In this optimization, W = 2 was 
used to represent relative weighting. 
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The mean cell death rate was calculated as 2.95 x 10-4 ± 6.36 x 10.5 
(h01 ). This is approximately equal to 1 % of the average value of division 
rates. No significant differences were observed between the cell death rates 
of control and arsenic-treated cell lines. 
4.6 Biologically-based dose-response (BBDR) model of the growth of SHE 
cells within one passage 
A BBDR model for the growth of SHE cells was developed after ce11 
division and death rates were measured. For normal SHE cells, Equation 1.1 
was applied into the model with the senescence rate (y) set equal to zero for 
early passages, which gives the simplified relation, 
dN(t) 
dt = N(t)·[a(t)- P] (4.3) 
where N denotes the number of normal cells, and a and ~ are the cell 
division and death rates, respectively. The measurement of cell division rate 
was discussed in section 4.4, and death rate in section 4.5. Since only 
normal and senescent stages will be discussed here, the subscript one in 
Equation 1.1 will be ignored. 
After every cell passage, there was a lag time in culture before cell 
division started. In the meantime, the cells spread out and adapted to the 
new environment. The lag time (T1ag) defined in this thesis is only for 
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modeling purposes; the mechanism of the lag phase was not studied here. 
The cell numbers were assumed to be unchanged during the lag time, and 
controlled by the division and death rates measured after T1ag • Cell counts 
from the third, fourth, and fifth days after cells were passaged were used to 
determine the value of T,ago The starting time of the integration of Equation 
4.3 which fitted the data best was determined to be T1ag • The optimization 
of T ,ag was achieved by a computer program (Appendix C) written in 
MATLAB® which minimized the objective function (Equation 4.5) between 
the integration (predicted) and cell counts (observed). 
The (ag time was determined to be 41 .9 hours, and the result of 
modeling output versus data is shown in Figure 4.7. The cell numbers 
remained unchanged between zero and 41 .9 hours, followed by a fast 
growing phase. As cell density increased, the cells grew at a lower rate due 
to the decreasing of space. The end point of this model was the time the 
next passage proceeded (seven days). 
4.7 BBDR model of the growth of SHE cells through the life span 
To apply the model to more than one passage, the dilution we made in 
each passage should be taken into account. The cell number used to verify 
the model (Ncorrected) was calculated as the cell number counted while cells 
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Time after cells being passaged (h) 
Figure 4.7. BBDR modeling of the growth of SHE cells within one passage 
The line represents the modeling output of differential equation 
dN (t) Idt :::: N (t) x [0 (t)-~] (Appendix C) with 41.9 hours of lag time (T'ag)' The 
dots represent the normal cell counts from the third, fourth, and fifth days 
after cells were passaged. 
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i.e. using the equation, 
N N corrected, i-1 
corrected, i == N count• i X 4 X 104 (4.6) 
where the value in denominator, 4 x 1 0 4 , is the cell number at the beginning 
of every passage. The integration of Equation 4.3 was used repeatedly for 
all passages, while the initial number of cells of each passage was equal to 
the last value of previous passage (Appendix D). The result of BBDR 
modeling output versus experiment data is shown in Figure 4.8. These cells 
had been treated by arsenic for 2 days at graded concentrations, i. e . • , 
control; 0, 0.5 11M; T, 1.0 11M; 0, 2.0 11M; 0, 5.4 11M. As is the case with a 
single passage (Figure 4. 7), there is a lag phase in the beginning of each 
passage, followed by a fast growing phase with low cell density. With the 
increasing of cell numbers, cells grew at a lower rate. Cells were passaged 
weekly and another lag phase started at this point. 
To further verify if the ability of arsenic to inhibit the growth of SHE 
cells, the standard error of estimating Tpot (Section 4.4) should be considered 
in the model. In other words, there is no significant difference among the 
growth of cell lines if their corrected cell numbers fall in the area between 
two lines which formed by the integration of Equation 4.3 with cell division 
rates calculated from Tpot ± 1.75 (h). The result in Figure 4.9 indicated that 
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Figure 4.8. BBDR modeling of the growth of SHE cells through the life span 
The line represents the modeling output where the integration of Equation 
4.3 was used repeatedly in every passage. The symbols represent the 
corrected cell numbers where the dilution factor at each passage was taken 
into account. These cells had been treated by arsenic for two days at graded 
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Figure 4.9. BBDR modeling of the growth of SHE cells with the standard 
error of estimating TpDt taken into account 
The solid line represents the modeling of SHE cell growth with cell division 
rate calculated from Equation 4. 1. The dashed lines reflect the uncertainty 
of the model based on the Tpot standard error (1.75 h). The symbols 
represent the corrected cen numbers of cells exposed to arsenic for two days 
at graded concentrations, i.e . • , control; D, 0.5 pM; ., 1.0 pM; 0, 2.0 pM; 
0,5.4 pM. 
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three low concentrations of arsenic and control cells. As we expected from 
the discussion in Section 4.3, SHE cells exposed to 5.4 pM of arsenic 
showed a significant inhibition of cell growth at the third and fourth 
passages. This cell line stop growing at the fourth passage. This gave us 
the information required for determining the cell senescence rate. 
It was also calculated by a computer program (Appendix E) that when 
the means of Tpot values multiplied by a factor of 0.93, the resulting model 
output fitted the control cell counts (e in Figure 4.9) best. 
4.8 The estimation of senescence rates 
The potential doubling times measured from the third and fourth 
passages of cells exposed 5.4 pM of arsenic were much higher than from the 
normal cells, which is the result of increases of senescent cells. These 
potential doubling times incorporated with the data collected from the 
growth of normal cells provided the information for estimating cell 
senescence rates. The senescence rate was assumed to be zero, prior to the 
third passage of this cell line. 
4.8.a The correlation between senescence rates and potential doubling times 
The potential doubling time measured reflected the growth of a 
population containing both normal and senescent cells. Thus the more 
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senescent cells existed in the population, the higher the Tpoto Base on this 
result and the observation from Figure 4.9, i.e. a significant inhibition of cell 
growth was observed at the third and fourth passages in this cell line, we 
concluded that cells exposed to 5.4 pM of arsenic started to become 
senescent at the third passage and continued the process at the fourth 
passage where all cells stopped growing. 
To calculate the number of senescent cells, Equation 1.3 was recalled 
and Equation 1.1 was rewritten as, 
dN(t) 
dt = N(t), [anormal (t) - ft] - r (t)· N(t) (4.7) 
dS(t) 
dt = r (t), N(t) (1.3) 
where Nand S denote the number of normal and senescent cells, 
respectively, and 0, p, and V denote the cell division, death, and senescence 
rates, respectively. The ceB death rate, p, was calculated in Section 4.5 and 
assumed to be constant. Cell division rate with subscript normal is the rate 
we discussed in Section 4.4. The division rate of normal cell (onormal) should 
be distinguished from the division rates measured at the third and fourth 
passages of the cells exposed to 5.4 pM of arsenic, 0mix t which is the rate of 
a mixed population of normal and senescent cells. Since 0mix reflected the 
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growth of the mixed population, we should discuss it from the summation of 
Equations 4.7 and 1 .3, i. e. 
d[N(t) + Set)] 
dt = N(t)· anormal(t) - N(t)· jJ (4.8) 
Since the potential doubling time, which was used to calculated cell division 
rate, was defined as a cell cycling time that takes growth fraction but not 
cell loss into account, Equation 4.8 was rewritten as, 
d[N(t~; S(t)] = [N(t) + S(t)]. amix(t)- N(t)· fJ (4.9) 
From Equation 4.8 and 4.9, the fraction of the normal cells in the mixed 
population was calculated as, 
N(t) ----.;--== 
N(t) + Set) anormal(t) 
(4.10) 
By incorporating Equation 3.1 into this equation, it could be rewritten as, 
N ( t ) Tpotllormal ( t ) --....;......;.--== 
N(t) + Set) Tpotmix (t) 
(4.11 ) 
According to our assumption that cells exposed to 5.4 pM of arsenic were in 
the process of becoming senescent at the third and fourth passages, cell 
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numbers counted in these passages were considered as the total number of 
normal and senescent cells, i.e. N(t) + S(t). Thus the numbers of normal as 
well as senescent cells at these two passages were calculated from Equation 
4.10 and cell counts. 
4.8.b The correction of the potential doubling time according to crowding 
factor 
While using Tpot values measured at the third and fourth passages to 
calculate the senescence rates, Tpot values were corrected according to the 
"crowding" factor because Tpot values are affected by both the IIsenescent" 
and II crowding" factors at these two passages. To correct the crowding 
factor, the change of Tpot as a function of cell number per plate is shown in 
Figure 4.10. The cell numbers were calculated by the same program used to 
predict the of growth of cells within one passage as shown in Figure 4.7. 
The division rates were calculated by means of Tpot values (Equation 4.1) 
multiplied by a factor of 0.93 to obtain the best fit to control cells (Section 
4.7). 
Whether the senescent cell populations had great impact on the Tpot 
values was verified by normalizing the Tpot values by the Tpot values measured 
at the third day after the cells were passaged (Figure 4.11 ). The normalized 
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Figure 4. 10. The change of potential doubling time fTpoJ as a function of cell 
density 
The means of Tpots (Equation 4.1) multiplied by a factor of 0.93 was used to 
calculate the division rates (0) in the equation, dN(t)/dt:= N(t) x [o(t}-[3], which 
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Figure 4. 11. The effect of senescent cell population on potential doubling 
time (Tpot)' 
Potential doubling times were normalized according to the value measured at 
the third day after passage in each cell line. The dashed-dot line represents 
the standard curve which on1y reflected the crowding factor on normalized 
Tpot and was normalized from Figure 4.10. The symbols, ., 0, ., and \) 
represent the normalized Tpots of control cells and cells exposed to the three 
lower concentration of As (0.5, 1.0, and 2.0 pM), respectively. 
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passage, with all data presented on a comparable scale. The standard curve, 
which represented a function that the change of Tpot values was only related 
to the crowding factor (dashed-dot line in Figure 4. 11), was normalized from 
Figure 4.10. In all samples shown in Figure 4.11, Tpot values were only 
measured on the third and fifth days after cell passage. 
The changes of the normalized Tpot values in control cells and cells 
exposed to the three lower concentration of arsenic (e, 0, T, and 0 in Figure 
4. 11) all followed the same pattern the standard curve had, which suggested 
their Tpot values were only affected by cell densities. For cells exposed to 
5.4 JiM of arsenic, the normalized Tpot values increased 1.76 and 1 .88 folds 
at third and fourth passages in a time span of 2 days, but with only slight 
increases in the cell numbers. The normalized Tpot values of standard curve 
only increased 1 .04 folds with the same amount of change in the cell 
numbers. These results suggested that the senescent cells in the population 
slowed the growth of the whole population. 
4.8.c The prediction of the growth of a cell population including normal and 
senescent cells 
For a cell population including both normal and senescent cells, the cell 
growth was much slower than for a population consisting only of normal 
cells. Therefore, the cell division rates calculated in Section 4.4 could not be 
69 
used here, i. e. the cell divisio!", rates applied to Equation 4.9 should be 
estimated separately. It was assumed that the changes of Tpot values with 
time of these mixed population followed the same pattern the normal cells 
had. Three parameters exponential equations similar to Equation 4.1 
(Tpot=Yo+aoeb.time; Yo' a, b are constants) can be used to fit the data of Tpot 
values versus time after passages. Available data for the mixed population 
cells were the Tpot values and cell numbers from third and fourth passages of 
the cells exposed to 5.4 pM of arsenic. Two Tpot values, at 72 and 1 20 
hours after cells being passaged, from each of these two passages were 
measured ° Since at least three data points were needed for the three 
parameters exponential equation, the cell number counted in the end of the 
passage was incorporated to the data fitting of Tpot ' The cell growth was 
simulated by a computer program (Appendix F) which first fitted the 
distribution of Tpot values with the three parameters exponential equation by 
finding the Tpot in the end of the passage, i.e. the Tpot resulting the calculated 
cell number fitted the experimental data best. The modeling predictions, 
which using the integration of Equation 4.9, of the cell growth of the mixed 
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Figure 4. 12. The prediction of the growth of a cell population including both 
normal and senescent cells 
The solid and dashed line represent the modeling predictions of the growth of 
the cells exposed to 5.4 pM of As at the third and fourth passages, 
respectively. The dots represent the experimental data of cell numbers from 
this cell line. The Tpots used in this model was optimized by the computer 
'program as shown in Appendix F, with the results that 
Tpot = 0.843 + 17.4 *eO.0120-t for the third passage and 
Tpot = 31.8 + 2.89*eo.025S-t for the fourth passage. 
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4.8.d The optimization of cell senescence rate 
The senescence rates (y) was defined as the values that result in the 
best predictions of the number of senescent cells (S) (calculated from 
Equation 1 .3) and normal cells (N) (calculated from Equation 4.7). The 
predicted numbers of senescent cells were verified by the experimental data 
calculated from Equation 4.11, whereas the summation of predicted normal 
and senescent cells were verified by the data calculated from Equation 4.9. 
The optimization of the cell senescence rates was achieved by a 
program (Appendix G) executed by ACSL. The results of optimization are 
shown in Figure 4.13 where the values between 336 and 528 hours 
represent the cell growth of the third passage of the cells exposed to 5.4 pM 
of arsenic and those between 528 and 768 hours represent the fourth 
passage. The senescence rates estimated was 0.0543 h-1 for the third 
passage and 0.057 h-1 for the fourth passage. The solid line and solid circles 
denote the experimental data of total and senescent cells, respectively. The 
predicted values of normal (from Equation 4.7), senescent (from Equation 
1 .3), and total cells (the summation of previous two numbers) are expressed 
by the dot, dashed, and dashed-dot lines, respectively. Most of the 
predicted numbers of senescent cells (dashed line) were higher than the 
experimental data (dots). The predicted numbers of total cells (dashed-dot 
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Figure 4. 13. The estimation of cell senescence rate 
the values between 336 and 528 hours represent the cell growth of the 
third passage of the cells exposed to 5.4 pM of arsenic and those between 
528 and 768 hours represent the fourth passage. The solid line and solid 
circles denote the experimental data of total and senescent cells, 
respectively. The predicted values of normal, senescent, and total cells are 
expressed by the dot, dashed, and dashed-dot lines, respectively. The 
estimated senescence rates were 0.0543 h-1 for the third passage and 0.057 
h-1 for the fourth passage. 
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lower at the fourth passages.~ 
The deviation of the predicted values from experimental data was 
assumed to be caused by the overestimated division rates of normal cells. A 
high senescence rate was obtained at third passage in order to compensate 
the overestimated division rate. The high senescence rate meant more 
normal cells becoming senescent cells, which resulting in the extremely low 
number of normal cells in the end of the third passage, i.e. in the beginning 
of the fourth passage. Since only the normal cells proliferated and the initial 
value was low, the total cell number was not able to match the experimental 
data in the fourth passage. 
The assumption that the division rates of normal cells were 
overestimated was based on the observation that the senescent cells were 
much larger than the normal cells (Figure 4.3). Since the senescent cells 
occupied much larger areas than the normal ceJJs did, i.e. normal cells grew 
slower in the mixed population than we estimated, the crowding factor for 
estimating cell division rates should be modified. It was estimated from a 
program written in ACSL (Appendix H) that the division rates of the normal 
cells should be multiplied by a factor of 0.34 to correct the crowding effect. 
The senescence rates were estimated as 0.0103 h-1 for the third passage and 
0.0175 h-1 for the fourth passage (Figure 4.14) with the corrected normal 
cell division rates. The model made very good predictions of the total cell 
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numbers. Unlike the results in Figure 4.13, the predicted cell numbers 
followed the same growth pattern the experimental data had at both the third 
and fourth passages in Figure 4.14. Although the prediction of senescent 
ceU numbers were not as good as of the total cell number, the experimental 
data of total cel) numbers, which were obtained directly from the counting, 
were more reliable than the data of senescent cell numbers calculated by the 
ratio of potential doubling times. The modeling predictions of the growth of 
the cells in mixed population was incorporated the predictions for normal 
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Figure 4. 14. The estimation of senescence rates with corrected normal cell 
division rates 
The normal cell division rates were multiplied by a factor of 0.34 to correct 
the crowding effect due to the different sizes of senescent and normal cells. 
Cell senescence rates were estimated as 0.0103 h-1 at the third passage and 
0.0175 hot at the fourth passage. As in Figure 4.13, the solid line and solid 
circles denote the experimental data of total and senescent cells, 
respectively. The predicted values of normal, senescent, and total cells are 
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Figure 4. 15. The modeling predictions of the gro wth of normal cells and 
cells in the population including both normal and senescent cells 
The solid line represents the modeling predictions of the growth of normal 
SHE cells. The dashed lines reflect the uncertainty of the model based on 
the Tpot standard error. The dashed-dot line represents the predictions of the 
growth of the cens in a mixed population including normal and senescent 
cells The symbols represent the cell numbers of cells exposed to arsenic for 
two days at graded concentrations, i.e . • , control; 0, 0.5 pM; "Y, 1.0 pM; 




The biologically-based dose-response model developed in our 
laboratory was proven to predict the growth of normal Syrian hamster 
embryo (SHE) cells successfully. The model was biologically-based since the 
cell division and death rates applied in the model were measured by flow 
cytometry, and the cell numbers calculated by the model were consistent 
with the experimental data. The flow cytometric methods used in here could 
be applied to other cell lines easily for modeling purpose. 
Results from cytotoxicity studies show that a mixture of the three 
metals (arsenic, chromium, and lead) are less-than-additive, suggesting 
antagonistic interaction at the level of cell killing. No immortal cell line was 
observed after serial passages of the cells exposed to the Le50 of the three 
metals individually and as a mixture. 
For normal SHE cells, the cell division rates decreased as cell densities 
increased due to the shortage of space for cell growth. The potential 
doubling times, which were directly measured by flow cytometry and used to 
calculated division rate, ranged from 12 to 59 hours, depending on the 
degree of confluence of cell cultures. As a result, a fast growth phase 
78 
followed the lag phase (Figure 4.9) and the cell growth slowed down as cell 
numbers increased. The cells were passaged once a week and another cycle 
followed the same growth pattern began then. The cell death rates we 
measured were much smaller than the division rate, which was a result 
expected under exponential growth conditions. 
SHE cells exposed for two days to 5.4 JJM of arsenic, which was the 
LCso of arsenic to SHE cells analyzed by MTT assays, expressed growth 
inhibition at the third and fourth passage. These cell lines only grew for 1 6 
population doublings before becoming senescent, while control cells and 
those exposed to lower concentrations of arsenic grew for at least 30 
population doublings. The cells exposed to lower concentrations, 0.5, 1.0, 
and 2.0 JJM, of arsenic did not express significant differences in growth rates 
from control cells. 
Cell senescence rates were estimated from the experimental data 
generated from the cells exposed to 5.4 JJM of arsenic. This cell line grew 
much more slowly than the control cell line during the third and fourth 
passages. This decreased growth rate was caused by the increase of 
senescent cells in the population. While estimating the senescence rate, the 
division rate of normal cells should be multiplied by a factor of 0.34 to 
correct the crowding effect due to the different sizes in normal and 
senescent cells. The senescence rates were measured as 0.0103 and 
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0.0175 h-1 for the third and fourth passages, respectively (Figure 4.14). 
Mechanisms responsible for induction of cellular senescence in SHE 
cells exposed to arsenic may be involved in the apparent inability of arsenic 
to induce neoplasia in experimental animals. The genetic changes associated 
with arsenic-induced senescence in vitro may be related to the absence of 
tumor development in test animals. In combination with an appropriate 
human in vitro system, the SHE cell system could serve as a tool for 
comparing differences in carcinogenic mechanisms of arsenic between 




All the techniques for measuring cell division and death rates 
developed in our laboratory could be applied to other cell lines for modeling 
purposes. The model has the potential to be applied to in vitro human cell 
lines, and further incorporate their in vivo counterpart with physiological-
based pharmacokinetic/pharmacodynamic modeling for risk assessment. 
With the successful prediction of the growth of Syrian hamster 
embryo (SHE) cells, it is worthwhile to improve the experimental system. 
The first improvement is to passage cells every five days instead seven days. 
Since the cell growth is strongly dependent on the crowding effect on the 
culture plate, a shorter period between each passage could reduce the impact 
of cell density on cell division rates. For example, the data in Figure 4.4 
imply that a 5-day passage frequency would be adequate, since the cells still 
grew at relative high rate at the fifth day before the crowding effect had 
strong impact on the growth. Furthermore, the consistency of the assay can 
be improved by quantifying the ratio of metabolizing to transformable cell 
types in the initial cell population. 
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Improvements also could be made to better estimate the cell 
senescence rates. In our experiments, we successfully predicted of total cell 
numbers with adjusted normal cel1 division rates, but the senescent cell 
numbers predicted were lower than the experimental data (Figure 4.13). In 
order to obtain more information for estimating the cell senescence rates, 
potential doubling times should be measured every day instead of the third 
and fifth days after cells start the process of becoming senescent. 
There was a lag phase, in which the cell numbers stayed unchanged, 
in the beginning of each passage in our model. This lag phase was actually a 
undetermined area where insufficient amount of cells were accumulated for 
flow cytometric analysis. To study the detail of the behavior of cells in this 
time period, the experiment should start with a large amount of cells in every 
passage. As a result, culture plates with larger area should be used to 
compensate the crowding effect caused by the increased initial cell numbers. 
To further study the abilities of the chemicals chosen in this thesis to 
induce neoplastic transformations in SHE cells for modeling purpose, it is 
worthwhile to repeat the experiments with seven day exposure instead of 
two day period. As soon as the cells immortal or later stages are obtained, 
the parameters of cell growth in each stage could be estimated and thus the 
quantitative cancer model will be completed. 
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The mutation rate jJ was not estimated in the thesis due to the 
unavailability of immortal cell lines. Since it is an important parameter in the 
model, the calculation of mutation rates are discussed as follows. 
Fluctuation analysis proposed by Luria and Delbruck (Luria and Delbruck, 
1 943) were widely used to estimate cell mutation rates in vitro (Crawford et 
al., 1983; Kraemer et al., 1986; Bois et al., 1991; Bois et al., 1992; 
Dumontet et al., 1996). The distribution of the numbers of mutation in 
series of similar cultures which are plated in parallel is analyzed (Luria and 
Delbruck, 1 943). The mutation rate is then calculated as 
(6.1 ) 
where v is the mutations per cell per division cycle, Po represents the fraction 
of culture with no mutants, Nf and No are the final and initial number of cell 
(Luria and Delbruck, 1943). The term (-In Po) in Equation 6.1 is the number 
of mutations per culture (m) calculated from the equation 
D -m 
.Lo = e (6.2) 
with the assumption that the distribution of all mutations is according to 
Poisson's law (Luria and Delbruck, 1943). For example, if one out of 30 
colonies isolated become immortal cell line in my experiment, the fraction of 
culture with no immortalization occurred {Po} is equal to 29/30 and the 
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number of mutation per culture (m) is 0.034. 
The mutation rate estimated by fluctuation analysis can not be directly 
applied to the model proposed in this thesis, since the mutation rate /11 in this 
model is defined as the probability of mutation that a stage i cell divides into 
one stage i cell and one stage i + 1 cell, i.e. the number of mutation per cell 
division. With the derivation discussed in Appendix I, the mutation rate /1 in 
the model can be calculated as 
(6.3) 
For the control cells in my experiments, isolated colonies can expand 
to approximately 5 x 106 cells (Nf), which is assumed to start with 1 cell (No), 
and no immortal cell lines were observed from 30 isolated colonies. Thus the 
spontaneously mutation rate /11 for normal cells become immortal cells is less 
than 
-In(29 / 30) 9 
---6--= 6.8 x 10- mutation per cell division 
5 x 10 -1 
Mutation rates have been broadly defined as mutation per cell per 
generation (Luria and Delbruck, 1943), mutation per viable cell (Bois, 
Naaktgeboren, and Simons, 1991), mutation per time unit (Moolgavkar and 
Knudson, Jr., 1981). With modeling purpose in SHE cell system, the 
84 





AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY (ATSDR), 
1990a. Case Studies in Environmental Medicine: Arsenic Toxicity. Atlanta: 
U.S. Department of Health and Human Services, Public Health Service. 
AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY (ATSDR), 
1990b. Case Studies in Environmental Medicine: Chromium Toxicity. Atlanta: 
U.S. Department of Health and Human Services, Public Health Service. 
AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY (ATSDR), 
1992. Case Studies in Environmental Medicine: Lead Toxicity. Atlanta: U.S. 
Department of Health and Human Services, Public Health Service. 
AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY (ATSDR), 
1993b. A TSDR: Chromium. Atlanta: U.S. Department of Health and Human 
Services, Public Health Service. 
AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY (ATSDR), 
1993d. A TSDR: Lead. Atlanta: U.S. Department of Health and Human 
Services, Public Health Service. 
AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY (ATSDR), 
1993a. Toxicological Profile for Arsenic. Atlanta: U.S. Department of Health 
and Human Services, Public Health Service. 
AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY (ATSDR), 
1993c. Toxicological Profile for Chromium. Atlanta: U.S. Department of 
Health and Human Services, Public Health Service. 
ALBERTS B, BRAY D, LEWIS J, RAFF M, ROBERTS K, WATSON JD, 1994. 
The Cell-Division Cycle. In: Molecular Biology of the Cell. New York: Garland 
Publishing, 863-910. 
86 
ARMITAGE P, DOLL R, 1954. The Age Distribution of Cancer and a Multi-
stage Theory of Carcinogenesis. British Journal of Cancer 8:1-12. 
ARMITAGE P, DOLL R, 1957. A Two-Stage Theory of Carcinogenesis in 
Relation to the Age Distribution of Human Cancer. British Journal of Cancer 
11:161-169. 
BALLANTYNE B, MARRS T, TURNER P, 1995. Fundamentals of Toxicology. 
In: General and Applied Toxicology. New York: Stockton Press, 3-38. 
BANDTLOW C, ZACHLEDER T, SCHWAB ME, 1990. Oligodendrocytes 
Arrest Neurite Growth by Contact Inhibition. The Journal of Neuroscience 
10:3837-3848. 
BARRETT JC, 1979. The Progressive Nature of Neoplastic Transformation of 
Syrian Hamster Embryo Cells in Culture. Progress in Experimental Tumor 
Research 24: 1 7-27. 
BARRETT JC, 1993. Neoplastic Progression of Syrian Hamster Embryo Cells 
in Culture. Proceedings of the Society for Experimental Biology and Medicine 
202:30-36. 
BEGG AC, MCNALLY NJ, SHRIEVE DC, KARCHER H, 1985. A Method to 
Measure the Duration of DNA Synthesis and the Potential Doubling Time 
From a Single Sample. Cytometry 6:620-626. 
BERWALD Y, SACHS L, 1963. In Vitro Cell Transformation with Chemical 
Carcinogens. Nature 200: 1182-1184. 
BERWALD Y, SACHS L, 1965. In Vitro Transformation of Normal Cells to 
Tumor Cells by Carcinogenic Hydrocarbons. Journal of the National Cancer 
Institute 35:641-661. 
BOLS BLMC, NAAKTGEBOREN JM, LOHMAN PHM, SlMONS JWIM, 1992. 
lmmortalization of Carcinogen-treated Syrian Hamster Embryo Cells Occurs 
Indirectly via an Induced Process. Cancer Research 52:2253-2256. 
SOLS BLMC, NAAKTGEBOREN JM, SIMONS JWIM, 1991. Immortalization 
of Syrian Hamster Embryo Cells Is in Itself a Multistep Event. Cancer 
Research 51 :1177-1184. 
87 
BOYD JA, BARRETT JC, 1990. Genetic and Cellular Basis of Multistep 
Carcinogenesis. Pharmacology and Therapeutics 46:469-486. 
COHEN MD, KARGACIN B, KLEIN CB, COSTA M, 1993. Mechanisms of 
Chromium Carcinogenicity and Toxicity. Critical Reviews in Toxicology 
23:255-281. 
CONOLLY RB, KIMBELL JS, 1994. Computer Simulation of Cell Growth 
Governed by Stochastic Processes: Application to Clonal Growth Cancer 
Models. Toxicology and Applied Pharmacology 124:284-295. 
COOPER GM, 1992a. Basic Facts About Cancer.ln: Elements of Human 
Cancer. Boston: Jones and Bartlett Publishers, 3-14. 
COOPER GM, 1992b. Cancer and the Environment.ln: Elements of Human 
Cancer. Boston: Jones and Bartlett Publishers, 31-62. 
COSTA M, 1997. Toxicity and Carcinogenicity of Cr(VI) in Animal Models 
and Humans. Critical Reviews in Toxicology 27:431-442. 
CRAWFORD BD, BARRETT JC, TS'O POP, 1983. Neoplastic Conversion of 
Preneoplastic Syrian Hamster Cells: Rate Estimation by Fluctuation Analysis. 
Molecular and Cellular Biology 3:931-945. 
CRUMP KS, 1996. The Linearized Multistage Model and the Future of 
Quantitative Risk Assessment. Human and Experimental Toxicology 15:787-
798. 
DEWANJI A, VENZON OJ, MOOLGAVKAR SH, 1989. A Stochastic Two-
Stage Model for Cancer Risk Assessment. II. The Number and Size of 
Premalignant Clones. Risk Analysis 9: 179-187. 
DUMONTET C, DURAN GE, STEGER KA, BEKETIC-ORESKOVIC L, SIKIC BI, 
1 996. Resistance Mechanisms in Human Sarcoma Mutants Derived by 
Single-Step Exposure to Paclitaxel (Taxol). Cancer Research 56: 1 091-1 097. 
GILMER TM, ANNAB LA, BARRETT JC, 1988. Characterization of Activated 
Proto-Oncogenes in Chemically Transformed Syrian Hamster Embryo Cells. 
Molecular Carcinogenesis 1: 1 80-1 88. 
HAD V, CRENSHAW T, MOULTON T, NEWCOMB E, TVCKO B, 1993. 
Tumour-Suppressor Activity of H19 RNA. Nature 365:764-767. 
88 
JOLLIFFE DM, 1993. A History of the Use of Arsenicals in Man. Journal of 
the Royal Society of Medicine 86:287-289. 
KANISAWA M, SCHROEDER HA, 1967. Life Term Studies on the Effects of 
Arsenic, Germanium, Tin, Vanadium on Spontaneous Tumors in Mice. Cancer 
Research 27:1192-1195. 
KLEINBAUM DG, KUPPER LL, MULLER KE, NIZAM A, 1998. Applied 
Regression Analysis and Other Multivariable Methods.Pacific Grove: Duxbury 
Press, 51-52. 
KOI M, AFSHARI CA, ANNAB LA, BARRETT JC, 1989. Role of a Tumor-
Suppressor Gene in the Negative Control of Anchorage-Independent Growth 
of Syrian Hamster Cells. Proceedings of the National Academy of Sciences of 
the United States of America 86:8773-8777. 
KOI M, BARRETT JC, 1986. Loss of Tumor-Suppressive Function during 
Chemically Induced Neoplastic Progression of Syrian Hamster Embryo Cells. 
Proceedings of the National Academy of Sciences of the United States of 
America 83:5992-5996. 
KRAEMER PM, RAY FA, BROTH MAN AR, BARTHOLDI MF, CRAM LS, 1986. 
Spontaneous Immortalization Rate of Cultured Chinese Hamster Cells. 
Journal of the National Cancer Institute 76:703-709. 
LARSEN JK, 1994. Measurement of Cytoplasmic and Nuclear Antigens.ln: 
Ormerod MG, ed. Flow Cytometry: A Practical Approach. Oxford: Oirl Press, 
93-117. 
LEBOEUF RA, KERCKAERT GA, 1986. The Induction of Transformed-like 
Morphology and Enhanced Growth in Syrian Hamster Embryo Cells Grown at 
Acidic pH. Carcinogenesis 7:1431-1440. 
LEBOEUF RA, KERCKAERT GA, AARDEMA MJ, GIBSON DP, 1990. 
Multistage Neoplastic Transformation of Syrian Hamster Embryo Cells 
Cultured at pH 6.70. Cancer Research 50:3722-3729. 
LEBOEUF RA, KERCKAERT GA, POlLEY JA, RAINERI R, 1989. An 
Interlaboratory Comparison of Enhanced Morphological Transformation of 
Syrian Hamster Embryo Cells Cultured under Conditions of Reduced 
Bicarbonate Concentration and pH. Mutation Research 222:205-218. 
89 
LEE TC, LEE KCC, CHANG C, JWO WL, 1986. Cell-Cycle Dependence of the 
Cytotoxicity and Clastogenicity of Sodium Arsenite in Chinese Hamster 
Ovary Cells. Bulletin of the Institute of Zoology, Academia Sinica 25:91-97. 
LURIA SE, DELBRUCK M, 1943. Mutations of Bacteria from Virus Sensitivity 
to Virus Resistance. Genetics 28 :491-511 . 
MOOLGAVKAR SH, 1979. Two-Event Models for Carcinogenesis: Incidence 
Curves for Childhood and Adult Tumors. Mathematical Biosciences 47:55-
77. 
MOOLGAVKAR SH, 1983. Model for Human Carcinogenesis: Action of 
Environmental Agents. Envirnomental Health Perspectives 50:285-291. 
MOOLGAVKAR SH, DAY NE, STEVENS RG, 1 980. Two-Stage Model for 
Carcinogenesis: Epidemiology of Breast Cancer in Females. Journal of the 
National Cancer Institute 65:559-569. 
MOOLGAVKAR SH, DEWANJI A, VENZON OJ, 1988. A Stochastic Two-
Stage Model for Cancer Risk Assessment. I. The Hazard Function and the 
Probability of Tumor. Risk Analysis 8:383-392. 
MOOLGAVKAR SH, KNUDSON AG, JR., 1981. Mutation and Cancer: A 
Model for Human Carcinogenesis. Journal of the National Cancer Institute 
66:1037-1052. 
MORTON WE, DUNNETTE DA, 1994. Health Effects of Environmental 
Arsenic.ln: Nriagu JO, ed. Arsenic in the Environment, Part II: Human Health 
and Ecosystem Effects. New York: John Wiley & Sons, Inc., 17-34. 
NORDLING CO, 1953. A New Theory on the Cancer-Inducing Mechanism. 
British Journal of Cancer 7:68-72. 
ORMEROD MG, 1994. Futther Applications to Cell Biology.ln: Ormerod MG, 
ed. Flow Cytometry: A Practical Approach. Oxford: Oirl Press, 261-273. 
PETERS LJ, 1996. Radiation Therapy Tolerance Limits. For One or for All? -
Janeway Lecture. Cancer 77 :2379-2385. 
PORTIER CJ, EDLER L, 1990. Two-Stage Models of Carcinogenesis, 
Classification of Agents, and Design of Experiments. Fundamental and 
Applied Toxicology 14:444-460. 
90 
POTT WA, BENJAMIN SA, YANG RSH, 1998. Antagonistic Interactions of 
an Arsenic-Containing Mixture in a Multiple Organ Carcinogenicity Bioassay. 
Cancer Letters 133:185-190. 
PRASAD GL, FULDNER RA, COOPER HL, 1993. Expression of Transduced 
Tropomyosin 1 cDNA Suppresses Neoplastic Growth of Cells Transformed by 
the ras Oncogene. Proceedings of the National Academy of Sciences of the 
United States of America 90:7039-7043. 
PRESTON GA, LANG JE, MARONPOT RR, BARRETT JC, 1994. Regulation of 
Apoptosis by Low Serum in Cells of Different Stages of Neoplastic 
Progression: Enhanced Susceptibility after Loss of a Senescence Gene and 
Decreased Susceptibility after Loss of a Tumor Suppressor Gene. Cancer 
Research 54:4214-4223. 
PUTNAM RD, 1986. Review of Toxicity of Inorganic Lead. American 
Industrial Hygiene Association Journal 47:700-703. 
Smith, T. B. Evaluation of Carcinogenic Potential of Chemical Mixtures 
Containing Arsenic and Volatile Organics. 1997. Colorado State University. 
Ref Type: Thesis/Dissertation 
SPSS INC., 1997. Transforms & Regressions Reference Manual for 
SigmaPlot.Chicago: SPSS Inc., 8-23-8-31 . 
STEEL GG, 1977. Basic theory of growing cell populations.ln: Steel GG, ed. 
Growth kinetics of tumours: cell population kinetics in relation to the growth 
and treatment of cancer. Oxford: Clarendon Press, 57-85. 
TAN WY, 1 991. Two-Stage Models of Carcinogenesis.ln: Stochastic Models 
of Carcinogenesis. New York: Marcel Dekker, Inc., 81-133. 
WEINBERG RA, 1996. How Cancer Arises. Scientific American 275:62-70. 
WILSON GD, 1994. Analysis of DNA-Measurement of Cell Kinetics by the 
Bromodeoxyuridine/Anti-bromodeoxyuridine Method.ln: Ormerod MG, ed. 
Flow Cytometry: A Practical Approach. Oxford: Oirl Press, 137-156. 
YAMAUCHI H, FOWLER BA, 1994. Toxicity and Metabolism of Inorganic and 
Methylated Arsenicals.ln: Nriagu JO, ed. Arsenic in the Environment, Part II: 
Human Health and Ecosystem Effects. New York: John Wiley & Sons, Inc., 
35-53. 
91 
Appendix A: Calculations of potential doubling times 
Part A Data used to calculate the T for normal ce11s in Figure 4 5* . oot . 
Cell isolate Passage Sampling Relative DNA Labeling Potential 
time (days movement synthesis time index doubling time 
after passage) (RM) (Ts; hour) (LI) (T pot; hour) 
Control 36 p4 2 days 0.87 4.1 0.320 13 
Control 40 p4 2 days 0.84 4.4 0.399 11 
Control 43 p4 2 days 0.87 4.0 0.346 12 
Control 15 p3 3 days 0.81 4.8 0.377 13 
Contro139 p3 3 days 0.85 4.3 0.327 13 
Control 43 p3 3 days 0.83 4.5 0.367 12 
Control 38 pI3 3 days 0.86 4.2 0.299 14 
Control 36 p8 3 days 0.83 4.5 0.260 17 
Control 38 p8 3 days 0.80 5.1 0.303 17 
Contro140 p8 3 days 0.87 4.1 0.239 17 
Control 38 p9 3 days 0.75 6.0 0.372 16 
Control 36 p4 4 days 0.81 4.8 0.232 21 
Contro140 p4 4 days 0.74 6.3 0.327 19 
Control 15 p3 5 days 0.77 5.6 0.248 23 
Control 36 p8 5 days 0.83 4.6 0.193 24 
Contro138 p8 5 days 0.80 5.0 0.198 25 
Control 40 p8 5 days 0.85 4.3 0.166 26 
Control 29 p2 5 days 0.78 5.8 0.197 30 
Control 38 p13 5 days 0.75 6.0 0.198 31 
Control 27 p3 5 days 0.74 6.3 0.240 26 
Control 34 p6 5 days 0.78 5.3 0.188 28 
Control 19 p3 5 days 0.71 7.1 0.229 31 
Control 15 p4 5 days 0.77 5.5 0.173 32 
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Part A. (Continued) 
Cell isolate Passage Sampling Relative DNA Labeling Potential 
time (days movement synthesis time index doubling time 
after passage) (RM) (Ts; hour) (LI) (Tpot; hour) 
Control 36 p9 6 days 0.74 6.2 0.112 55 
Contro138 p9 6 days 0.73 6.5 0.102 63 
Control 27 p4 6 days 0.71 7.1 0.109 65 
Control 34 p7 6 days 0.70 7.5 0.161 46 
Control 19 p4 6 days 0.66 9.2 0.142 65 
* All sample were fixed by 70% ethanol at 3 hours after BrdU pulse-labeling 
Part B. Data measured for growth inhibition study by arsenic* 
Cell isolate Passage Sampling Relative DNA Labeling Potential 
time (days movement synthesis time index doubling time 
after passage) (RM) (Ts; hour) (LI) (Tpot; hour) 
Control I p4 3 days 0.81 4.8 0.395 12 
Arsenic 0.5 p4 3 days 0.82 4.7 0.342 14 
Arsenic 1.0 p4 3 days 0.79 5.2 0.362 14 
Arsenic 2.0 p4 3 days 0.81 4.8 0.315 15 
Arsenic 5.4 p3 3 days 0.78 5.3 0.128 42 
Arsenic 5.4 p4 3 days 0.77 5.6 0.114 50 
Control I p4 5 days 0.75 6.0 0.243 25 
Arsenic 0.5 p4 5 days 0.79 5.2 0.237 22 
Arsenic 1.0 p4 5 days 0.76 5.7 0.221 26 
Arsenic 2.0 p4 5 days 0.75 6.0 0.235 25 
Arsenic 5.4 p3 5 days 0.74 6.3 0.086 74 
Arsenic 5.4 p4 5 days 0.76 5.8 0.062 94 
* All sample were fixed by 70% ethanol at 3 hours after BrdU pulse-labeling 
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Appendix B: Optimization of cell death rate 
%This is a program written in Matlab to optimize cell death rates by 
%"fmins" command, a built-in function in Matlab to minimize the given 
%function using a NeIder-Mead type simplex search method, with function 
%file "Dr_mf". Function file "Dr_df" is used to solve differential 
%equations. 
clear 
tc=[O 24 50.25]; %Sampling times (h) 
%Experimental data of live cells 
%Experimental data of dead cells 
Nc=[9.25E4 2.00E5 5.125E5]; 
Dc=[1073 2060 3792.5]; 
r=2i %Heteroscedasticity parameter in Objective Function; r=2: relative 
%weighting 
BN=fmins ( 'Dr_mf' , [0.00027 Nc (1) Dc (1) ] , [] , [] , r, tc, Nc, Dc) ; 
%BN: optimization results; In parenthesis after fmins: filename of 
%function file, initial guess, options, blank, and parameters 
%passed to function file; 
beta=BN (1) %Cell death rate (h- 1 ) 
NO=BN{2:3) %Optimized initial numbers of live and dead cells 
[t,N]=ode23 ('Dr_df' , [0:1:60] ,NO, [] ,beta) i 
%ode23: the built-in function in Matlab for solving ordinary 
%differential equation using Runge-Kutta 2nd order algorithm; N: 
%the solutions for differential equations with respect to time, t 
%(h); N(l) : live cells, N(2): dead cells. In parenthesis after 
%ode23: filename of function file, time span, initial values, 
%blank, parameter passed to function file. 
semilogy(t,N,tc,NC, 'o',tc,Dc, ,A,) 
xlabel('Time (h) ') 
ylabel('Cell Number') 
title('Prediction of Death Rate') 
%Plot experimental and simulation 
%data on semi-log plot 
%This is the function file, "Dr_mf", to optimize cell death rate 
function err=Dr_mf(BN,r,tc,Nc,Dc) 
%err: function to be minimized; BN: variables to be adjusted; r, 
%tc, Nc, Dc: parameters passed from main program 
beta=BN (1); %Cell death rate (h-1 ) 
94 
NO=BN(2:3}j %Optimized initial numbers of live and dead cells 
[tiN] =ode23 ('Dr_dfl, [tc 60] ,NO, [] ,beta) i 
err=O; 
for i=l:length(Dc) 
errl=(N(i,l) -Nc{I» ..... 2./Nc(I) ..... r; 





%Objective function for live 
%cells 
%Objective function for dead 
%cells 
%This is the function file, "Dr_dfll, to solve differential equations 
function NP=Dr df{t,N,init,beta) 
%NP(l): dN/dtj NP(2): dD/dtj init: default setting; beta: cell 





p9=1.0824e-013j plO=-S.3390e-8j pll=O.0554j 
alfa=pl*N{l) .A10+p2 *N(l) ."'9+p3*N(1) .A8+p4 *N(1) ."'7+p5*N(1) .A 6+p6*N(1) ."'5+ 
p7*N(1) ..... 4+p8*N(1) ..... 3+p9*N{1) .A2+plO *N(1) ..... l+pllj 
%alfa: cell division rates (h- 1), functions of cell number per 
%dish, N(l), fitted by a polynomial of degree 10. 
NP(l, :)=N(l) .*(alfa-beta)j 




Appendix C: Optimization of lag time 
%This is a program written in Matlab to optimize lag time by "fmins" 
%command, a built-in function in Matlab to minimize the given function 
%using a NeIder-Mead type simplex search method, with function file 
%"Tl mf". Function file "TI df" is used to solve differential 
%equations. 
clear 
NO=4e4; %Initial number of normal cell per dish 
tc7=[69.5 93.25 117.5]; 
NC38_7=[2.35ES 3.7SE5 9.70E5]; 
tc8=[71.33 95.17 112.5]; 
Nc38_8=[2.70ES 4.90E5 8.S0ES]; 
%Experimental data of sampling time 
%Experimental data of cell number 
%Experimental data of sampling time 
%Experimental data of cell number 
[tc I]=sort([tc7 tc8]); %Data collected from different experiments are 
%sorted by magnitude for optimization program 
Nns=[Nc38_7 Nc38_8]; 
Nc=Nns(I); 
r=2i %Heteroscedasticity parameter; r=2: relative weighting 
Tlag=fmins('TI_mf', [42.4], [], [] ,r,tc,Nc) 
%Tlag: optimization result of lag time; In parenthesis after 
%fmins: filename of function file, initial guess, options, blank, 
%and parameters passed to function file; 
[t, N] =ode23 ( 'TI_df' , [Tlag 43: 1: 168] ,NO) i 
%ode23: the built-in function in Matlab for solving ordinary 
%differential equation using Runge-Kutta 2nd order algorithm; N: 
%number of normal cells solved by differential equations with 
%respect to time, t (h). In parenthesis after ode23: filename of 
%function file, time span, initial values. 
yO=12.4363; a=9.132E2; b=4.323E2; 
Tpot=yO+a*exp(b*t); %Potential doubling time (h); a function of 
%time, t 
plot{ [O;t], [NOiN] ,tc7,Nc38_7, 'x' ,tc8,Nc38_8, '0 1 ) 
%Plot predicted and experimental results 
xlabel('Time after cells being passaged (h) ') 
ylabel('Cell Number') 
title{'Simulation of the Growth of NORMAL Cell within One Passage') 
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%This is the function file, "TI_mf", to optimize lag time 
function err=TI_mf{Tlag,r,tc,Nc) 
%err: function to be minimized; Tlag: variables to be adjusted; 
%r, tc, Nc: parameters passed from main program. 
NO=4e4; %Initial number of normal cell per dish 
[t,N]=ode23{'TI_df', [Tlag tc 168] ,NO); 
%Solving differential equations 
err=O; 
for i=l:length(tc) 
err1=(N(I+1)-Nc(I» ."'2./Nc(I) ."'ri 
err=err+errl; 
end 
%Objective function for normal 
%cells 
%This is the function file, "TI_df", to solve differential equations 
function NP=Tl_df(t,N) %NP: dN/dt 
yO=12.4363; a=9.132E-2; b=4.323E-2; 
Tpot=yO+a*exp(b*t)i %Potential doubling time; a function of time, t 
alfa(1)=log(2)/Tpot; 
beta(1)=O.000295j 
%Cell division rate (hOl ); alfa={ln 2)/Tpot 
%Cell death rate (hol ) 
NP(l, :)=N(l) .*(alfa(l)-beta(l)} i %dN/dt=N*(alfa-beta) 
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Appendix 0: BBDR model of the growth of SHE cells 
%This is a program written in Matlab to model the growth of SHE cells. 
clear 
NOpl=4e4.*ones(3,1)i %Initial number of normal cells at passage 1 
%For Passage 1 
[ttpl, N2pl (: ,1)] =ode23 ('mdl_tfl' , [41.9,43: 1: 168] , NOpl (1) ) ; 
%ode23: the built-in function in Matlab for solving ordinary 
%differential equation using Runge-Kutta 2nd order algorithm; 
%N2pl(:,I) number of normal cells in exponential growth phase 
%solved by differential equations with respect to time, ttpl. In 
%parenthesis after ode23: filename of function file, time span, 
%initial value. 
tp1=[O;ttpl]i %Time points in Passage 1; exponential and lag phases 
Npl(:,l)=[NOpl{l) iN2pl(:,I)]i %Normal cell number in Passage 1; 
%exponential and lag phases 
NOp2(1)=N2pl(length(N2pl{:,1»,1); %Initial number for Passage 2 
%For upper bound of uncertainty of model in Passage 1 
[ttpl,N2pl (:, 2)] =ode23 ('mdl_tfe', [41.9,43: 1: 168] ,NOpl (2) , [] ,I) ; 
%N2pl(:,2) upper bound of normal cells in exponential growth phase 
%solved by differential equations with respect to time, ttpl. In 
%parenthesis after ode23: filename of function file, time span, 
%initial value, blank, parameter passed to function file (1: upper 
%bound) . 
NOp2(2)=N2pl{length(N2pl{:,2»,2)i 
%Upper bound of normal cell number in Passage 1; exponential and 
%lag phases 
Npl{:,2)=[NOpl(2)i N2pl{:,2)]i 
%Initial value for upper bound in Passage 2 
%For lower bound of uncertainty of model in Passage 1 
[ttpl,N2pl (: , 3)] =ode23 ('mdl_tfe' , [41.9,43: 1: 168] ,NOpl (3) , [] , -1) ; 
%N2pl(:,3) lower bound of normal cells in exponential growth phase 
%solved by differential equations with respect to time, ttpl. In 
%parenthesis after ode23: filename of function file, time span, 
%initial value, blank, parameter passed to function file (-I: 
%lower bound) . 
NOp2(3)=N2pl(length(N2pl(:,3»,3) ; 
%Lower bound of normal cell number in Passage 1; exponential and 
%lag phases 
Npl(:,3)=[NOpl(3)i N2pl(:,3»)i 
%Initial value for lower bound in Passage 2 
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%For Passage 2; refer to the section of Passage 1 
[ttp2,N2p2 (:,1)] =ode23 ('mdl_tf1', [41.9,43 :1:168] ,NOp2 (1»; 
tp2=[tp1(length(tp1» ;ttp2+tp1(length{tp1»]; 
%Transfer the time points from those based on single passage 
%(ttp2) to based on life span (tp2); the differential equation was 
%solved at time points based on single passage since the potential 
%doubling times are functions of time after passage 
Np2(:,1)=[NOp2(1);N2p2(:,1)]; 
NOp3(1)=N2p2{length(N2p2(:,1» ,1); 
%For upper bound of uncertainty of model in Passage 2 
[ttp2,N2p2(:,2)]=ode23('mdl_tfe', [41.9,43:1:168] ,NOp2(2), [] ,1); 
NOp3(2)=N2p2(length{N2p2(:,2» ,2); 
Np2 ( : ,2) = [NOp2 (2) ;N2p2 ( : (2) ] ; 
%For lower bound of uncertainty of model in Passage 2 
[ttp2,N2p2 (: ,3)] =ode23 ('mdl_tfe', [41.9,43 :1:168] ,NOp2 (3), [], -1); 
NOp3(3)=N2p2(length{N2p2(:,3»,3); 
Np2 ( : , 3) = [NOp2 (3) ; N2p2 ( : , 3) ] ; 
%For Passage 3; refer to the section of Passage 1 and 2 
[ttp3,N2p3 (: ,1)] =ode23 ('mdl_tf1', [41.9,43:1: 192] ,NOp3 (1» ; 
tp3=[tp2(length(tp2» ;ttp3+tp2(length(tp2»]; 
Np3(:,l)=[NOp3(1);N2p3(:,l)]; 
NOp4 (1)=N2p3(length{N2p3 (:,1» ,1); 
%For upper bound of uncertainty of model in Passage 3 
[ttp3,N2p3 (: ,2)] =ode23 ('mdl_tfe', [41.9,43 :1:192] ,NOp3 (2), [], 1); 
NOp4(2)=N2p3{length(N2p3(:,2»,2); 
Np3 ( : ,2) = [NOp3 (2) ;N2p3 ( : ,2) ] ; 
%For lower bound of uncertainty of model in Passage 3 
[ttp3,N2p3(:,3)]=ode23 ('mdl_tfe', [41.9,43:1:192] ,NOp3(3), [] ,-1); 
NOp4 (3)=N2p3 (length (N2p3 (:,3» ,3); 
Np3 ( : , 3) = [NOp3 (3) ; N2p3 ( : , 3) ] ; 
%For Passage 4; refer to the section of Passage 1 and 2 
[ttp4,N2p4 (: ,1)] =ode23 ('mdl_tf1', [41.9,43 :1:216] ,NOp4 (1» ; 
tp4=[tp3(length(tp3»;ttp4+tp3(length(tp3»] ; 
Np4 ( : , 1) = [NOp4 (1) i N2p4 ( : , 1) ] i 
NOp5(1)=N2p4(length{N2p4{:,l»,l)i 
%For upper bound of uncertainty of model in Passage 4 
[ttp4,N2p4 (: ,2)] =ode23 ('mdl_tfe' , [41.9,43: 1 :216] ,NOp4 (2) , [] ,1) i 
NOpS(2)=N2p4(length(N2p4(:,2»,2); 
Np4{:,2)=[NOp4(2);N2p4{:,2)]i 
%For lower bound of uncertainty of model in Passage 4 
[ttp4,N2p4 (:,3)] =ode23 ('mdl_tfe', [41.9,43 :1:216] ,NOp4 (3), [] ,-1); 
NOpS(3)=N2p4(length(N2p4{:,3»,3) ; 
Np4 ( : , 3) = [NOp4 (3) i N2p4 ( : , 3) ] ; 
%For Passage S; refer to the section of Passage 1 and 2 
[ttpS ,N2pS (: ,1) ] =ode23 ('mdl_tf1' , [41.9,43: 1: 168] ,NOpS (1) ) ; 
tpS=[tp4(length(tp4» ;ttpS+tp4(length{tp4»]; 
NpS(:,l)=[NOpS{1)i N2pS(:,1)] ; 
NOp6(1)=N2pS(length(N2p5{:,1»,1); 
%For upper bound of uncertainty of model in Passage S 




%For lower bound of uncertainty of model in Passage 5 
[ttpS,N2pS(:,3)]=ode23 {lmdl_tfe' , [41.9,43:1:168] ,NOpS(3), [] ,-I) j 
NOp6(3)=N2pS(length(N2pS(:,3»,3)i 
NpS ( : , 3) = [NOpS (3) j N2pS ( : , 3) ] j 
tcount=[0,168,336,528,744] j %Sampling times for groups other than S.4 
%tLM of As 
tcount54=[O,168,336,528,768] j %Sampling times for cells exposed to 5.4 
%tLM of As 
N_ctrl=[4.00E4 3.06E6 1.90E8 1.2SE10 8.39Ell] j 
%Cell counts for control cells 
N_as05=[4.00E4 2.08E6 9.98E7 5.39E9 2.10E11]j 
%Cell counts for cells exposed to O.S tLM of As 
N_asl=[4.00E4 1.88E6 9.40E7 4.89E9 1.7IE11]j 
%Cell counts for cells exposed to 1 tLM of As 
N_as2=[4.00E4 1.48E6 4.74E7 1.99E9 7.76EIO] j 
%Cell counts for cells exposed to 2 tLM of As 
N_as54=[4.00E4 1.20E6 2.64E7 1.32E8 4.62E8]j 
%Cell counts for cells exposed to S.4 tLM of As 




semilogy {tpl, Npl ( : ,2: 3) , 1 - • 1 ,tp2, Np2 ( : ,2: 3) , , - . I , tp3, Np3 ( : ,2: 3) , I_ 
• I , tp4 , Np4 ( : ,2 : 3) , I - • 1 , tpS, NpS ( : ,2 : 3) , I - • I ) 
semilogy(tcount,N_ctrl, '+',tcount,N_asOS, 'p',tcount,N_asl, 's',tcount,N_a 
s2, Id',tcountS4,N_asS4, 'hI) 
hold off 
xlabel('Time after passage (h) I) 
ylabel('Cell Number'} 
title('Simulation of Cell Growth through 5 Passages') 
%This is the function file, umdl_tfl", to solve differential equation 
function NP=mdl_tfl(t,N) %NP: dN/dt 
yO=12.4363j a=9.132E-2; b=4.323E-2j 
Tpot=yO+a*exp{b*t); %Potential doubling time; function of time, t 
alfa(l}=log(2)/Tpotj %Cell division rate; alfa=(ln 2)/Tpot 
beta(l)=0.00029Sj %Cell death rate 
NP(l, :)=N(l) .*(alfa(l)-beta(l)} i %dN/dt=N*(alfa-beta) 
%This is the function file, umdl_tfe", to solve differential equations 
function NP=mdl_tfe(t,N,init,Pl) 
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if Pl==O %Cell division rate calculated by the mean of Tpot 
Tpot=yO+a*exp(b*t); %Potential doubling time; function of time, t 
elseif Pl>O %Upper bound: cell division rate calculated by Tpot + 
%standard error of estimating Tpot 
Tpot=1.7454+yO+a*exp(b*t)i 
else %Lower bound; cell division rate calculated by Tpot -





%Cell division rate; alfa=(ln 2)/Tpot 
%Cell death rate 
NP (1, :) =N (1) . * (alfa (1) -beta (1» ; %dN/dt=N*(alfa-beta) 
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Appendix E: Optimization of potential doubling time 
%This is a program written in Matlab to optimize lag time by "fmins" 
%command, a built-in function in Matlab to minimize the given function, 
%i.e. optimize the factor that the mean of potential doubling time have 
%to be multiplied by to provide best prediction of control cell line, 
%using a NeIder-Mead type simplex search method, with function file 
%\\Tl_mf". Function file "TI_df" is used to solve differential 
%equations. 
clear 
NO=4e4; %Initial number of normal cell per dish 
r=2; %Heteroscedasticity parameter; r=2: relative weighting 
Sigma=fmins ( I Si_mf I , [1] , [] , [] , r) 
%Sigma: optimization result of the factor that the mean of 
%potential doubling time have to be multiplied by to provide best 
%prediction of control cell line; In parenthesis after fmins: 
%filename of function file, initial guess, options, blank, and 
%parameters passed to function filei 
[t,N] =ode23 ('Si_dfl, [41.9 43 :1:168] ,NO, [] ,Sigma) i 
%ode23: the built-in function in Matlab for solving ordinary 
%differential equation using Runge-Kutta 2nd order algorithm; N: 
%number of normal cells solved by differential equations with 
%respect to time, t. In parenthesis after ode23: filename of 
%function file, time span, initial values, blank, parameter passed 
%to function file. 
yO=12.4363i a=9.132E-02i b=4.323E-02; 
Tpot=yO+a*exp(b*t); %Potential doubling time; function of time, t 
%The next section is the simulation of cell growth through 5 passages 
%Passage 1 
NOp(1)=4e4; %Initial number of normal cells at passage 1 
[ttp1,N2p1] =ode23 (I Si_df', [41.9 43: 1: 168] ,NOp (1) , [] I Sigma) ; 
%N2p1 number of normal cells in exponential growth phase solved by 
%differential equations with respect to time, ttp1. In parenthesis 
%after ode23: filename of function file, time span, initial value, 
%parameter (optimized result) passed to function file. 
tp1=[O;ttp11i %Time points in Passage 1; exponential and lag phases 
Np1=[NOp(1)iN2p1]i %Normal cell number in Passage 1; exponential 
%and lag phases 
NOp(2)=N2p1(length{N2p1»i %Initial number for Passage 2 
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%Passage 2 
[ttp2,N2p2]=ode23 ('Si_df' ,[41..9 43:1:1681 ,NOp{2), [] ,Sigma}; 
tp2=[tp1(length(tp1»;ttp2+tp1(length(tp1»] ; 
%Transfer the time points from those based on single passage 
%(ttp2) to based on life span (tp2); the differential equation was 
%solved at time points based on single passage since the potential 









[ttp4,N2p4]=ode23 ('Si_df', [41.9 43:1:216] ,NOp(4), [] ,Sigma) i 




[ttp5, N2ps] =ode23 (' Si_df' , [41.9 43: 1: 168] , NOp (5) , [] , Sigma) ; 
tp5=[tp4{length(tp4» itt pS+tp4(length(tp4»] i 
NpS=[NOp(s);N2p5] ; 
tcount=[0,168,336,528,744]i %Sampling times for groups other than 5.4 
%J.LM of As 
tcount54=[O,168,336,528,768]; %Sampling times for cells exposed to 5.4 
%JlM of As 
N_ctrl=[4.00E4 3.06E6 1.90E8 1.2sEIO 8.39E11]i 
%Cell counts for control cells 
N_as05=[4.00E4 2.08E6 9.98E7 5.39E9 2.10E11]; 
%Cell counts for cells exposed to 0.5 JlM of As 
N_as1=[4.00E4 1.88E6 9.40E7 4.89E9 1.71E11]; 
%Cell counts for cells exposed to 1 J.LM of As 
N_as2=[4.00E4 1.48E6 4.74E7 1.99E9 7.76E10] i 
%Cell counts for cells exposed to 2 JlM of As 
N_as54=[4.00E4 1.20E6 2.64E7 1.32E8 4.62E8]i 
%Cell counts for cells exposed to 5.4 JlM of As 




semilogy(tcount,N_ctrl, '+',tcount,N_asOs, 'p',tcount,N_as1, 's',tcount,N_a 
s2, 'd',tcounts4,N_ass4, 'hI) 
hold off 
xlabel('Time after passage (h) ') 
ylabel{'Cell Number') 
title('Simulation of Cell Growth through 5 Passages') 
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%The next section is the curve fitting of cell division rate versus cell 
%number per dish 
p=polyfit(N,log(2) ./(Sigma.*Tpot) ,10); 
%Finds the coefficients of a polynomial peN) of degree 10 that 
%fits the data in a least-squares sensei 10g(2) ./(Sigma*Tpot): 
%cell division rate. 
%Plot the curve fitting and experimental results 
figure 
plot (N,10g{2) ./(Sigma.*Tpot» 
hold on 
plot {N,polyval (p,N) , ,+,) 
hold off 
xlabel{'Cell number per plate') 
ylabel{'Division rate, alfa (l/h)') 
title('Cell division rate versus cell density') 
%This is the function file, "Si_mf", to optimize the factor that the 
%mean of potential doubling time have to be multiplied by to provide 
%best prediction of control cell line. 
function err=Si_mf(Sigma,r) 
%err: function to be minimized; Sigma: variables to be adjusted; 
%r: parameter passed from main program. 
%The next section is the simulation of cell growth through S passages; 
%refer to main program illustrated above 
NOp(1)=4e4; 




[ttp2,N2p2] =ode23 ('Si_df', [41.9 43:1:168] ,NOp(2), [] ,Sigma); %216 
tp2=[tp1(length(tp1»i ttp2+tp1(length(tpl»]i 
Np2=[NOp(2)i N2p2] ; 
NOp(3)=N2p2(length(N2p2»j 




[ttp4,N2p4] =ode23 ('Si_df', [41.9 43 :1:216] ,NOp (4), [] ,Sigma) i %216 
tp4=[tp3(length(tp3»jttp4+tp3(length(tp3»]i 
Np4=[NOp(4)i N2 p4]i 
NOp(S)=N2p4(length{N2p4»i 





N_ctrl=[4.00E+04 3.06E+06 1.90E+08 1.25E+10 8.39E+ll]; 
err=O; 
for i=2:length(N ctrl) 
errl=(NOp{i)-N ctrl(i}} .A2 ./N ctrl{i) .Ari - - %Objective function err=err+errli 
end 
%This is the function file, "Si_df", to solve differential equations 
function NP=Si_df(t,N/init,Sigma) 
%NP: dN/dti init: default setting; Sigma: parameter passed from 
%main program. 
yO=12.4363i a=9.132E-02i b=4.323E-02i 
Tpot=yO+a*exp{b*t}; %Potential doubling time; function of time, t 
alfa(1)=log(2)/(Sigma*Tpot)i 
beta(1)=O.OOO295i 
%Cell division rate; alfa=(ln2)/Sigma*Tpot 
%Cell death rate 
NP{l, :)=N(l}.* (alfa(l) -beta(l»; %dN/dt=N*(alfa-beta) 
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Appendix F: Prediction of the growth of a mixed cell population 
%This is a program written in Matlab to predict the growth of a mixed 
%cell population including normal and senescent cells, where the cell 
%division rates are optimized using 2 experimental data for Tpot and 1 
%data from cell counts. A 3-parameter exponential equation is used to 
%predict the distribution of Tpot via the "fmins" command, a built-in 
%function in Matlab to minimize the given function using a NeIder-Mead 
%type simplex search method, with function files "Cf_mf" and "Cf_cff". 
%Function file "Cf df" is used to solve differential equations. 
clear 
tf=192; Nf=2e5; 
Tpm=[42 74] i 
%Nf is cell number counted at time tf 
%Tpots measured at 72 and 120 hours after passage 
NO=4e4i %Initial cell number 
Tpf=fmins ( I Cf_mf I, [1000] , [] , [] , Tpm, tf, Nf) 
%Tpf: optimized result for the Tpot at time tf; In parenthesis 
%after fmins: filename of function file, initial guess, options, 
%blank, and parameters passed to function file; 
ts=[72 120 tf] '; 
Tp= [Tpm Tpf] I i 
%Sampling times, 72, 120, and tf hours after passage 
%TpotS i experimental data Tpm and optimized result Tpf 
%The distribution of Tpot is optimized using function file "ef_mf" as 
%described above. The next 4 lines are used to calculate the optimized 
%result via the equation Tpot=C(1)+c(2)*exp(lambda*t) which is written in 
%a matrix form Tp=A*c; Tp denotes Tpot ; t is time after passage. Details 
%are described in the function file "Cf_mf". 




[t, N] =ode23 ( I Cf_df I , [41.9,43: 1: tfl , NO, [] , lambda, c) ; 
%ode23: the built-in function in Matlab for solving ordinary 
%differential equation using Runge-Kutta 2nd order algorithm; N: 
%total cell numbers solved by differential equations with respect 
%to time t. In parenthesis after ode23: filename of function file, 
%time span, initial value, blank, parameters passed to function 
%file {"lambda" and "c" allow function file to use optimized Tpot 
%distribution to calculate cell division rate} . 
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%Plot experimental and predicted results 
plot{t,N,tf,Nf"A,) 
xlabel('Time after passage (h) ') 
ylabel(1Cell Number') 
title('Cell Number vs. Time for As 5.4 p3 1 ) 
%This is the function file, "Cf_mf", to optimize the distribution of Tpot 
%using 2 experimental data for Tpot and 1 data from cell counts via the 
%equation Tpot=c (1) +c (2) *exp (lambda*t); t: time after passage 
function err=Cf mf(Tpf,Tpm,tf,Nf) 
%err: function to be minimized; Tpf: variables to be adjusted; 
%Tpm, tf, Nf: parameter passed from main program. 
NO=4e4i %Initial cell number 
ts=[72 120 tfl'i %Sampling times, 72, 120, and tf hours after passage 
Tp= [Tprn Tpf] , ; % TpotS ; experimental data (Tpm) and value to be 
%optimized Tpf 
%The next section is to optimize the 3 parameters (c(l), c(2), lambda) 
%in the equation Tpot=c(1)+c(2)*exp(lambda*t) which is written in matrix 
%form Tp=A*c; Tp denotes Tpot 
lambda=fmins ( 'Cf_cff I ,0.01, [] , [] , ts, Tp) ; 
%lambda: optimized result; In parenthesis after fmins: filename of 
%function file, initial guess, options, blank, and parameters 




[t,N] =ode23 (' Cf df', [41.9,43: 1: tfl ,NO, [] , lambda, c) ; 
%Solve differential equation; N: total cell numbers solved by 
%differential equations with respect to time t. In parenthesis 
%after ode23: filename of function file, time span, initial value, 
%blank, parameters passed to function file ("lambda" and "c" allow 
%function file to use optimized Tpot distribution to calculate cell 
%division rate) . 
err=abs{N(length{N»-Nf) %Error of the predicted cell number at 
%time tf 
%This is the function file, "ef_cff", to optimize the 3 parameters 
% (c (1), c (2), lambda) in the equation Tpot=C (1) +c (2) *exp (lambda*t) which 
%is written in matrix form Tp=A*c; Tp denotes Tpot 
function err = Cf_cff(larnbda,ts,Tp) 
%err: function to be minimized; lambda: variables to be adjusted; 







A*Ci %Predicted values for TpotS 
err = norm(z-Tp)i %Norm of the vector containing errors between 
%predicted values (z) and experimental data (Tp) 
%This is the function file, "Cf_df", to solve differential equations 
function NP=Cf_df(t,N,init,lambda,c) 
%NP: dN/dt; init: default setting; lambda, c: parameters passed 
%from main program. 
%Cell division rates are calculated by the optimized Tpot distribution: 







%Cell division ratei alfa=(ln2)/Tpot 
%Cell death rate 
NP (1, :) =N (1) . * (alfa (1) -beta (1» i %dN/dt=N*(alfa-beta) 
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Appendix G: Optimization of senescence rate without adjusting division rates 
!This is a program written in ACSL to optimize cell senescence rates y 
!by ACSL Optimize with the parameter saved in "Cr3.m" file. 
PROGRAM Senescence rate estimation 
INITIAL 
VARIABLE TIME=O. 
CONSTANT NO=4e4 !Initial number of normal cells 
CONSTANT SO=O.O !Initial number of senescent cells 
CONSTANT gammal=0.OS74 !Initial guess for y at 3rd passage 
CONSTANT gamma2=0.0574 !Initial guess for V at 4th passage 
CONSTANT beta=0.000295 !Cell death rate (l/h) 
!Constants start with "p" are the parameters in the polynomial which 
!describes the relation between cell division rates and cell numbers 
CONSTANT pl=4.l462e-64, p2=-S.9308e-57, p3=3.6672e-50 
CONSTANT p4=-1.2847e-43, pS=2.8100e-37, p6=-3.9935e-31 
CONSTANT p7=3.7338e-25, p8=-2.30l3e-19, p9=9.6871e-14 
CONSTANT p10=-5.0492e-8, p11=0.05912858 
TSTOP=432. !Length of experiments (hour) 
POINTS=TSTOP*2. !Number of points in plot 
CINT=TSTOP/POINTS !Communication interval 
END !End of Initial Segment 
DYNAMIC 
DERIVATIVE 
!Lag phase at passage 3 
IF (TIME .LE. 41.9) THEN 
RN=O. !RN: Rate of change for normal cell # 
RS=O. !RS: Rate of change for senescent cell # 
!Exponential growth phase at passage 3 
ELSE IF (TIME .LE. 192.) THEN 
alfa=p1*NS**10+p2*NS**9+p3*NS**8+p4*NS**7+p5*NS**6+p6*NS**S+& 
p7*NS**4+p8*NS**3+p9*NS**2+plO*NS**1+pl1 
!alfa: cell division rate (l/h); function of cell number; NS: 
!total # of cells 
RN=N*(alfa-beta-gamma1) !N: normal cell # 
RS=N*gamma1 
!Lag phase at passage 4 
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!Exponential growth phase at passage 4 
ELSE 
NSF=NS*4e4/NS30 







N=INTEG (RN, NO) 
S=INTEG(RS,SO) 
NS=N+S 
!Integrate RN (dN/dt) with initial value NO 
!Integrate RS (dS/dt) with initial value SO 
END lEnd of Derivative Segment 
TERMT(TIME .GE. TSTOP) 
END !End of Dynamic Segment 
END !End of program 
IThis is the command file 





!suppress output from schedule 
!suppress hihg volume display 
!suppress output 
start !run the simulation as soon as loaded 
%This is the m file which saved the parameters of optimization 
% File: Cr3.m 
% Optimization algorithm 
% Values: 0 test run, 1 default, 2 NeIder-Mead, 3 GRG2 
OpAlgorithm = 3 
% Do not use the data set feature. 
OpDataSets = [] 
% Experimental data 
% The data values themselves. 
OpExperData = [ ••. 
gamma] 
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% The names of the data matrices. 
% (Used for display only.) 
OpDataNames = [ ... 
IIgamma ll ] 
% The enable/disable flags for data matrices. 
% (Used for display only.) 
OpEnable = [ ... 
1 ] r 
% Model variables to fit against experimental data. 
OpTargetNames = [ 
"NSII ... 
IISI1 ] 
% Error model. Rows correspond to variables being fit. 
% First column: heteroscedasticity parameter. 
% Second column: whether to vary heteroscedasticity parameter or hold it 
fixed. 
OpErrModel= [ ... 
2 0 
2 0] 
% ACSL constants to be adjusted as parameters. 
OpAdjustable= [ ... 
"GAMMA1" 
"GAMMA2" ], 
% Starting values. 
OpStartValues = [ 
0.0574 
0.0574 ]' 
% Constrained parameters (if any). 














OpDescriptors = [ ] 
OpExogColumns = [ ] 
% Descriptor values 
% Descriptor values for the enabled data matrices 
OpAllExpers = [] 
OpExperiments = [] 
% Exogenous data 
OpAllExogNames = [] 
% No exogenous data are present. 
OpExogData = [] 
% Scripts run for each experiment. 
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% No special commands are run before each experiment is simulated. 
OpScriptNames = [] 
OpAllScriptNames = [] 
% Whether objective function is displayed during parameter estimation. 
OpVerbose=O 
% Whether we run scripts at conclusion 
% 0 = run no scripts, 1 = run if successful, 2 
OpConcludeAct=l 




% End of file 
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run always 
Appendix H: Optimization of senescence rate with corrected division rates 
!This is a program written in ACSL to optimize cell senescence rates V 
!with modified division rate (multiplied division rate a by a factor 5) 
fusing ACSL Optimize with the parameter saved in "CrS.m" file. 
PROGRAM Senescence rate estimation with modified division rate 
INITIAL 
VARIABLE TIME=O. 
CONSTANT NO=4e4 !Initial number of normal cells 
CONSTANT SO=O.O !Initial number of senescent cells 
CONSTANT gamma1=O.0574 !Initial guess for V at 3rd passage 
CONSTANT gamma2=O.OS74 !Initial guess for V at 4th passage 
CONSTANT beta=0.000295 !Cell death rate (l/h) 
CONSTANT delta=l. !Initial guess for 5 
!Constants start with "pll are the parameters in the polynomial which 
!describes the relation between cell division rates and cell numbers 
CONSTANT pl=4.1462e-64, p2=-5.9308e-57, p3=3.6672e-50 
CONSTANT p4=-1.2847e-43, p5=2.8100e-37, p6=-3.9935e-31 
CONSTANT p7=3.7338e-25, p8=-2.3013e-19, p9=9.6871e-14 
CONSTAnT plO=-5.0492e-8, p11=O.05912858 
TSTOP=432. !Length of experiments (hour) 
POINTS=TSTOP*2. !Number of points in plot 
CINT=TSTOP/POINTS !Communication interval 
END !End of Initial Segment 
DYNAMIC 
DERIVATIVE 
lLag phase at passage 3 
IF (TIME .LE. 41.9) THEN 
RN=O. !RN: Rate of change for normal cell # 
RS=O. !RS: Rate of change for senescent cell # 
!Exponential growth phase at passage 3 
ELSE IF (TIME .LE. 192.) THEN 
alfa=pl*NS**lO+p2*NS**9+p3*NS**8+p4*NS**7+p5*NS**6+p6*NS**5+& 
p7*NS**4+p8*NS**3+p9*NS**2+plO*NS**1+pl1 
!alfa: cell division rate (l/h); function of cell number; NS: 
!total # of cells 
RN=N*(delta*alfa-beta-gammal) 
IN: normal cell #i alfa is multiplied by the factor delta 
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RS=N*gammal 
[Lag phase at passage 4 




[Exponential growth phase at passage 4 
ELSE 
NSF=NS*4e4/NS30 










[Integrate RN (dN/dt) with initial value NO 
!Integrate RS (dS/dt) with initial value SO 
END !End of Derivative Segment 
TERMT(TIME .GE. TSTOP) 
END lEnd of Dynamic Segment 
END lEnd of program 
!This is the command file 





!suppress output from schedule 
[suppress hihg volume display 
!suppress output 
start !run the simulation as soon as loaded 
%This is the m file which saved the parameters of optimization 
% File: CrS.m 
% optimization algorithm 
% values: 0 test run, 1 default, 2 NeIder-Mead, 3 GRG2 
OpAlgorithm = 3 
% Do not use the data set feature. 
OpDataSets = [] 
% Experimental data 
% The data values themselves. 
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OpExperData = [ ... 
gamma] 
% The names of the data matrices. 
% (Used for display only.) 
OpDataNames = [ ... 
"gamma 11 ] 
% The enable/disable flags for data matrices. 
% (Used for display only.) 
OpEnable = [ ••• 
1 ] I 
% Model variables to fit against experimental data. 
OpTargetNames = [ 
"NS" ... 
liS" ] 
% Error model. Rows correspond to variables being fit. 
% First column: heteroscedasticity parameter. 
% Second column: whether to vary heteroscedasticity parameter or hold it 
fixed. 
OpErrModel= [ ... 
2 0 
2 0] 
% ACSL constants to be adjusted. 




% Starting values of the ACSL constants. 
OpStartValues = [ 
1 0.0574 0.0574 ] 
% Constraints. 
% List of parameters on which there are constraints. 
OpConstrained = [ ••• 
"DELTAII .. . 





% Constraints themselves. One constraint per row. 







OpDescriptors = [ ] 
OpExogColurnns = [ ] 
% Descriptor values 
% Descriptor values for the enabled data matrices 
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OpAllExpers ;:;; [] 
OpExperiments = [] 
% Exogenous data 
OpAllExogNames = [] 
% No exogenous data are present. 
OpExogData = [) 
% Scripts run for each experiment. 
% No special commands are run before each experiment is simulated. 
OpScriptNames = [] 
OpAllScriptNames = [] 
% Whether objective function is displayed during parameter estimation. 
OpVerbose=O 
% Whether we run scripts at conclusion 
% 0 ;:;; run no scripts, 1 = run if successful, 2 = run always 
OpConcludeAct=l 




% End of file 
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Appendix I: Derivation of mutation rates 
The mutation rate J1 is modified from fluctuation analysis proposed by 
Luria and Delbruck {32}. The derivation of mutation rates discussed here is 
represented by the immortalization of normal cells. In Chapter 1, the 
mutation rate J1, is used in Equation 1.2 that 
dIet) 
dt = I(t)- [a2(t)- P2(t)] + Pt(t)- al(t)· N(t) (1.2) 
where I and N are the number of immortal and normal cells, respectively, O 2 
and ~2 are the division and death rates of immortal cells, 0 1 is the division 
rate of norma' cells, and Jl1 represents the probability of mutation that a 
normal cell divides into one normal cell and one immortal cell, i.e. the number 
of mutation per cell division. In contrast, the mutation rate obtained from 
fluctuation analysis (v) is defined as the mutations per cell per division cycle 
and calculated as 
(6.1 ) 
where Po represents the fraction of culture with no mutants, Nf and No are 
the final and initial number of cell {32}. 
To modified v for the modeling purpose, the relation between the unit 




(I. 1 ) 
When t = 0, 1: is equal to O. When t = {In 2)/01, i.e. potential doubling time, 1: 
is equal to 1 at which cells complete one division cycle. Since it is assumed 
that mutation only occurs at cell division, potential doubling time is counted 
as cell cycle time which ignores the impact of cell death. 
With division cycle defined as above, the number of immortal cells 
mutated from normal cells (1m) during time interval dt is calculated as 
117 
dI = v·N·dr m 
at = v·N·(-·dt) 
In2 
(1.2) 
where a, is assumed to be constant. This assumption is true from passage 
to passage, since the cell division rates are very consistent between 
passages in my experiments. However, in order to fully accomplish the 
assumption, experimental design should be modified that cells have to be 
passaged before confluency is reached to reduce the impact of crowding 
factor on division rates 0, within each passage. 
By applying Equation 6.1 into Equation 1.2, dIm can be rewritten as 
-lnR 
dI = 0 • a . N· dt (1.3) 
m N -N t 
f 0 
By comparing Equation 1.3 to Equation 1.2, the mutation rate J11 in the 
model can be calculated as 
-lnR o 
PI= N -N 
f 0 
(1.4) 
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